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A B S T R A C T
Laminin-5 Mediates Vascular Smooth Muscle 
Cell Response to Growth Factors
by
Karl Kingsley
Dr. George Plopper, Examination Committee Chair 
Assistant Professor of Biological Sciences 
University of Nevada, Las Vegas
The development and normal function of cells in the body 
depend upon interactions with other molecules. One such 
group of molecules, referred to as the extracellular 
matrix (ECM), is secreted by subsets of epithelial, 
endothelial, and mesenchymal cells within multicellular 
organisms. The laminin families comprise a set of 
soluble ECM glycoproteins that are required for 
structural integrity and development in many epithelial 
tissues. Ln-5 is a laminin isoform composed of three 
subunits: a3, P3, and y2. In this study, I sought to 
determine temporal and spatial patterns of ln-5 
expression in non-epithelial tissues. Using an enzyme- 
linked immunofluorescence amplification system and a
iix
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newly developed photobleaching treatment, I observed In- 
5 expression in previously undocumented sites including 
vascular smooth muscle cells (VSMC) of the aorta, 
pulmonary arteries, and also in bone and cartilage. In 
adult animals, VSMC are terminally differentiated and 
control blood flow and contraction in response to 
various chemical and mechanical stimuli. However, 
during the formation of atherosclerotic and restenotic 
lesions, VSMCs revert to a synthetic a phenotype 
characterized by a secretory-, proliferative-, and 
migratory-active state. I analyzed the functional 
significance of ln-5 expression, which is upregulated by 
growth factors induced following arterial injury. I 
found that ln-5 significantly altered the proliferation 
of VSMC in response to platelet-derived growth factor 
(PDGF-BB), a potent mitogen and chemoattractant for 
VSMC. I demonstrated that the a6pi and the a6p4 integrin 
complex may be responsible for the initial VSMC adhesion 
to ln-5. I also demonstrated that ln-5 does not support 
haptotactic VSMC migration, however PDGF-BB-stimulation 
greatly enhanced VSMC migration on ln-5. I therefore 
postulated that PDGF-BB-stimulated MAPK activation is 
responsible for the increased migratory phenotype of 
VSMC on ln-5 and found stimulation of VSMC with PDGF-BB
I V
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reduced VSMC adhesion to ln-5 and concomitantly 
increased VSMC migration on ln-5 while revealing 
detectable increases in ERKl/2 activation. As ln-5 is 
involved in the enhanced migration of various cell 
types, the increased production and decreased adhesion 
of VSMC on ln-5 may provide a mechanism for the design 
of novel and interesting targets in the prevention of 
pathological processes associated with the arterial 
vasculature, such as restenosis following angioplasty.
V
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CHAPTER 1
GENERAL INTRODUCTION 
Atherosclerosis is one of the leading causes of death 
in the United States [1]. Atherosclerosis is 
characterized by the accumulation of materials on the 
luminal face of a blood vessel, usually lipoproteins 
and fibrous tissue. These materials form lesions that 
protrude into the vessel lumen, effectively hindering 
diffusion of nutrients from the blood to the deeper 
tissues of the artery wall while simultaneously 
narrowing the lumen, thereby limiting blood flow. The 
accumulation of flow-limiting lesions can be 
exacerbated by inactivity, smoking, and stress and have 
been known to increase the risk of heart attack and 
stroke [2]. Although many treatments exist for the 
treatment of atherosclerosis, the most common 
treatments include arterial bypass surgery and 
angioplasty [3].
Angioplasty is a much faster, cheaper, less risky 
method of intervention than the more invasive treatment 
of arterial bypass surgery. Angioplasty is often
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
useful for treatment of localized obstructions and is 
performed on the scale of 300,000 or more per year in 
the United States alone [4]. Angioplasty involves the 
use of a catheter with a balloon tightly packed into 
the tip. Once the inserted catheter reaches the site 
of obstruction, the balloon is then inflated and the 
lesion is compressed against the artery wall, often 
breaking apart and thus reducing occlusion in patients 
suffering from severe arterial stenosis [5,6].
The long-term success of angioplasty treatment has been 
limited, at least in part, by reocclusion that occurs 
in some patients due to the erosion of the endothelium 
during the angioplasty procedure, and by the 
development of intimai hyperplasia (restenosis) in the 
area of the treated lesion in up to 50% of these 
procedures [7]. Due to the tremendous number of 
patients affected by atherosclerosis and the vascular 
remodeling known as restenosis following angioplasty 
treatment, the development of therapies to prevent and 
decrease restenosis has become a medical imperative.
Two major events contribute to restenosis, or the 
remodeling of the arterial vasculature, following 
injury. The first event is the migration of
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
proliferating vascular smooth muscle cells (VSMC) from 
the media of the vessel wall into the vessel lumen, 
contributing to the initial formation of a neointima. 
The second event is the subsequent proliferation of 
neointimal VSMCs, which leads to thickening of the 
neointima and to further occlusion. Both VSMC 
migration and the subsequent proliferation are events 
that are central to the formation of restenosis after 
injury, produced in response to an array of growth 
factors and extracellular matrix (ECM) proteins 
secreted locally at the sites of vascular remodeling 
[8] .
Each phase of cellular response is the cumulative 
response of VSMC to a complex network of stimuli that 
include loss of cell-cell interactions, altered ECM 
deposition and secretion, and plasma components 
including the localized release of growth factors.
These polypeptide growth factors, derived from 
platelets, macrophages, endothelial cells and VSMC 
themselves, are thought to be responsible, in part, for 
these phases of VSMC proliferation and migration 
associated with restenosis [9]. Growth factors that 
have been demonstrated to be VSMC mitogens in vitro and 
are thought to mediate phenotypic modulation of
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
migration and proliferation in vivo include basic 
fibroblast growth factor (bFGF) [10], epidermal growth 
factor (EGF) [11], transforming growth factor beta-1 
(TGF-pi), and platelet-derived growth factor (PDGF)
[12]. These factors, while not usually expressed in 
the normal artery, are upregulated after endothelial 
injury following angioplasty. These cytokines and 
growth factors regulate SMC responses such as 
proliferation, migration, and ECM production through 
ligation and activation of receptor tyrosine and 
serine-threonine kinases.
The loss of the integrity of the basement membrane and 
the subsequent exposure of VSMC to cytokines and 
upregulated ECM, produced by both endothelial cells and 
other VSMCs, may provide the signals that transform 
VSMC from the contractile phenotype to the 
proliferative and migratory phenotype following injury. 
ECM proteins such as fibronectin and laminin-1 are 
known to mediate both the proliferative and migratory 
phenotype of VSMC in pathological states such as 
atherosclerosis and restenosis [13].
The ECM plays several key roles in the maintenance and 
development of vertebrate organisms, in some cases
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
serving to separate two adjacent groups of cells to 
preclude any interactions between them, while in other 
cases the ECM may serve as a substrate that induces the 
migration or differentiation of specific cell types
[14]. The extracellular matrix is broadly defined to 
include a wide variety of secreted molecules that are 
immobilized outside the plasma membrane of the cell
[15] .
The ECM of most tissues is comprised of three major 
constituents: proteoglycans, collagen, and
glycoproteins [16]. Proteoglycans are specific types 
of glycoproteins where the interconnection of protein 
and carbohydrates form a web-like matrix, which 
mediates both the consistency of the matrix and the 
interactions of the cells contained within it.
Collagen is a family of secreted proteins that provides 
the major structural support of almost every animal 
organ, constituting nearly half of the total body 
protein of most animals. Finally, ECM glycoproteins 
include a variety of specialized molecules such as 
fibronectin (FN) and laminin (In).
The non-collagenous ECM glycoproteins serve a variety 
of specialized functions and include a number of
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
soluble multiadhesive matrix proteins that bind 
proteoglycans and collagen fibers to receptors on the 
cell surface [17]. These ECM glycoproteins function to 
provide more than an inert framework merely supports 
cells of a tissue, and rather provide the means by 
which cells can communicate directly and indirectly 
with the ECM to stimulate intracellular signaling 
pathways affecting cellular adhesion, growth, 
migration, and differentiation.
The laminin families comprise one set of soluble ECM 
glycoproteins that include multiple isoforms, required 
for structural integrity and development in many 
tissues. Each laminin molecule is composed of three 
non-identical subunits, an a-, p-, and y-subunit that 
share homology and assemble into a cross-like structure 
with one long and three short arms [18]. The amino 
terminus of the a-, p-, and y- subunits separately form 
the three short arms, whereas the three chains fold 
together in a coiled-coil structure to form the length 
of the carboxy-terminal long arm (Figure 1). After 
type IV collagen, laminins are the most prevalent 
constituent of all basal laminae.
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Each laminin subunit is a multidomain protein encoded 
by a distinct gene [19]. Different a, P, and y chain 
isomers combine to give rise to different 
heterotrimeric laminin isoforms (Figure 2). These 
isoforms perform similar functions but vary with 
respect to their tissue distribution, and presumably 
their diverse tissue-specific functions in vivo. For 
example, laminin-1 expression is regulated by 
epithelial-mesenchymal interactions and is implicated 
in airway smooth muscle development that occurs 
concurrently with cardiac enlargement and arterial 
expansion during development [20].
Ln-5 is a laminin isoform composed of three subunits 
designated a3, P3, and y2. Expression of the P3 and y2 
subunit have only been found in ln-5 while the a3 
subunit is found in both ln-6 and ln-7. Ln-5 is 
expressed in distinct temporal and spatial patterns in 
developing epithelial tissues and influences tissue 
compartmentalization and cellular phenotypes from early 
embryonic development onward [21].
Ln-5 has been detected primarily in the vertebrate 
endoderm and ectoderm, where it is abundantly expressed 
in the basement membrane of epithelial and endothelial
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
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tissues. These tissues include the oral, nasal and 
olfactory epithelium, intestine and stomach, bronchi 
and bronchioli, and breast [22 - 26]. In these tissues 
ln-5 has been shown to mediate growth, morphogenesis, 
and wound healing [27 - 29].
Ln-5 is expressed in distinct temporal and spatial 
patterns in developing epithelial tissues and 
influences tissue compartmentalization and cellular 
phenotypes from early embryonic development onward. 
However, the expression of ln-5 in non-epithelial 
tissues has been unreported to date. Because ln-5 plays 
a key role in controlling the growth and movement of 
epithelial cells, it is possible that it may play a 
similar role in mesoderm tissue, beginning in embryonic 
development and continuing in neonatal and adult 
tissues. We now know that ECM proteins such as FN and 
In are able to mediate the proliferative and migratory 
phenotype of arterial smooth muscle cells in vivo and 
in vitro, but because previous expression studies have 
failed to detect the ln-5 isoform in non-epithelial 
tissues, it is likely that ln-5, if expressed, is found 
in very low abundance in these tissues [30, 31].
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The goal of this study was to determine temporal and 
spatial patterns of ln-5 expression in non-epithelial 
tissues. Using an enzyme-linked immunofluorescence 
amplification system and a newly developed 
photobleaching treatment, I observed ln-5 expression in 
previously undocumented sites including the aorta, 
pulmonary arteries, bone, and cartilage. I 
demonstrated the spatial and temporal regulation of In- 
5 isoform expression in the developing tissues of the 
rib and examined the expression of ln-5 during 
embryonic vasculogenesis as well as in the adult 
animal.
Based on my in vivo observations and focusing on the 
vasculature, I hypothesized, that VSMC in the arterial 
vasculature express ln-5. In the remainder of this 
study, I attempted to analyze the functional 
significance of ln-5 expression.
My studies demonstrated that ln-5 supported cell 
proliferation in the absence of growth factor- 
stimulation, and further enhanced proliferation in the 
presence of specific growth factors. I also observed 
that while other ECM molecules such as collagen IV, 
laminin-1, fibronectin, and vitronectin support
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
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haptotactic migration of VSMC, ln-5 does not. 
Interestingly, platelet-derived growth factor (PDGF- 
BB)- stimulation greatly enhanced VSMC migration on In- 
5.
Based on these observations, I hypothesized that ln-5 
may differentially affect the proliferation and 
migration of VSMC and may also serve to mediate the 
migratory response of VSMC to growth factors such as 
PDGF-BB. Furthermore, because PDGF acts primarily 
through activation of the MAPK cascade, I postulated 
that PDGF-BB-stimulated MAPK activation is responsible 
for the increased migratory phenotype of VSMC on ln-5. 
Alterations to VSMC phenotype can be induced by 
integrin-receptor mediated MAPK activation as well as 
growth-factor receptor-mediated MAPK activation, thus 
VSMC phenotypic changes in response to ln-5 might 
provide novel and interesting targets in the prevention 
of pathological processes associated with the arterial 
vasculature, such as restenosis following angioplasty 
(Figure 3). The remainder of this study describes the 
discovery process and the functional significance of 
ln-5 expression by VSMC.
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Amplification and Autofluorescence
Standard immunohistochemical techniques are often not 
sensitive enough for the detection of low-level protein 
expression in situ. This was also true in the case of 
non-epithelial expression of ln-5. Enzymatic 
amplification of the specific fluorescent signal above 
background is one means of overcoming this problem. For 
example the use of a fluorogenic phosphatase substrate, 
2-(5'-chloro-2'-phosphoryloxyphenyl)-6-chloro-4-[3H]- 
quinazolinone, otherwise known as the ELF-substrate, 
alone has improved sensitivity in several circumstances 
[32]. The ELF-substrate produces a photostable 
precipitate upon dephosphorylation that amplifies 
antibody detection of low-abundance antigens in 
immunohistochemical analyses.
Although ELF alone significantly improves sensitivity 
in several tissues, its effect cannot overcome the 
complications associated with endogenous 
autofluorescence. Endogenous fluorescent molecules 
containing multiple tissue fluorophores complicate the 
use of immunofluorescence labeling in tissues such as 
the arterial vasculature, especially when attempts are 
made to localize low-abundance antigens in this tissue. 
In addition to elastin and collagen, cholesterol.
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fluorescent lipids, and other compounds further 
complicate spectral analysis of this tissue [33].
I attempted to reduce the endogenous autofluorescence 
using a number of photobleaching techniques. I tested 
several different conditions and determined which had 
the greatest reduction in tissue arterial 
autofluorescence. Using defined conditions of filtered 
sunlight to decrease autofluorescence in conjunction 
with signal amplification using the ELF substrate, I 
was able to observe low-level antigen localization that 
was distinguishable from endogenous autofluorescence.
I observed ln-5 expression in previously undocumented 
sites including the aorta, pulmonary arteries, bone, 
and cartilage.
Ln-5 expression in bone and cartilage
I confirmed several previously published sites of ln-5 
expression in the developing and neonatal rat using 
immunohistochemistry. In addition to these sites, I 
identified expression of the a3, pS, and y2 chains in 
the developing chondrocytes and areas of fibrocartilage 
matrix production in the rib. In this study I 
demonstrated the spatial and temporal regulation of In-
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
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5 isoform expression in the developing tissues of the 
rib.
During skeletogenesis, the pattern of ECM components 
produced by the differentiating cell types, and 
consequently the organization of the ECM molecules, 
changes to provide the template of the future skeleton 
[34]. The skeleton is comprised of two main tissue 
types, cartilage and bone. These two tissue types can 
be further subdivided into individual cell types; the 
chondrocyte in cartilage, the osteoblast and osteoclast 
in bone.
These cell types play an important role in both major 
modes of bone formation, intramembranous ossification, 
which is involved in the formation of the flat bones of 
the skull, and endochrondral ossification, which is 
involved in the formation of the vertebrae, ribs, 
pelvis, and the extremities. The secretion of a 
specialized ECM is one of the earliest functional 
changes in bone development and may be crucial for the 
establishment of specific microenvironments that drive 
differentiation in these cell types. This study 
provided the first conclusive evidence of novel 
laminin-5 isoform expression in the developing rib
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during mid- and late-stage bone development, a critical 
period of interactions between cells and the ECM.
Ln-5 expression in the arterial vasculature
In addition to these sites, I identified expression of 
the a3, P3, and y2 chains in the layers of the aorta 
and pulmonary artery, beginning at embryonic day 14, 
which is sustained throughout late gestation into the 
adult. Based on my in vivo observations, I hypothesized 
that rat vascular smooth muscle cells express ln-5. 
Immunofluorescence microscopy, western blot analysis, 
and RT-PCR provided further support of my initial 
observations that the ln-5 isoform is expressed in 
vascular smooth muscle tissue.
Xs^lications of ln-5 expression by VSMC
VSMCs are the predominant cell type found in the media 
of elastic and muscular arteries of mammals. In 
adults, VSMC are terminally differentiated and control 
blood flow and contraction in response to various 
chemical and mechanical stimuli. However, during the 
formation of atherosclerotic and restenotic lesions, 
VSMCs revert to a synthetic phenotype characterized by 
a secretory-, proliferative-, and migratory-active 
state.
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The reversion of VSMC from a differentiated to a 
synthetic phenotype may be caused by disturbances in 
integrin-matrix interactions, which are thought to 
underlie or contribute to many vascular pathologies. 
Abnormal extracellular matrix accumulation is an 
important component in the pathophysiology of lesions 
involving hyperplasia, associated with restenosis.
Intimai thickening after a lesion, such as that 
inflicted in angioplasty, occurs in stages. The first 
stage is characterized by VSMC proliferation and 
migration into what will become the neointima. During 
the second stage, the VSMC fill the neointima with 
matrix. Experimental models show that a large number 
of VSMC proliferate in the first 72 hours after injury 
and that this proliferation occurs concomitant with the 
phenotypic modulation of VSMC from a contractile to a 
synthetic phenotype. In addition to cell growth, these 
phenotypic modulations lead to an increased production 
of a number of ECM molecules that interact with cell 
adhesion receptors to mediate many of these phenotypic 
cellular behaviors.
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In the remainder of this study, I attempted to analyze 
the functional significance of ln-5 expression, which 
is upregulated by TGF-pl and PDGF-BB, two growth 
factors induced following arterial injury involved in 
the regulation of SMC responses such as migration and 
proliferation. As the initial phase of VSMC in response 
to the injury or trauma is characterized by VSMC 
proliferation within the tunica media, I analyzed the 
relationship in VSMC proliferation between ln-5 and 
growth factors that have been demonstrated to be VSMC 
mitogens in vitro and are thought to mediate phenotypic 
modulation of migration and proliferation in vivo.
VSMC proliferation on ln-5
The loss of the integrity of the basement membrane and 
the subsequent exposure of VSMC to cytokines and 
upregulated ECM by endothelial cells and other VSMCs 
provide the signals that transform VSMC from the 
contractile phenotype to the proliferative and 
migratory phenotype following injury. My results 
demonstrated that ln-5 significantly alters the 
proliferation of VSMC in response to PDGF-BB, a potent 
mitogen and chemoattractant for VSMC. Interestingly, 
ln-5 expression is also upregulated by PDGF-BB and TGF- 
Pl ,  suggesting that ln-5 may be involved in mediating
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
1 7
VSMC response to PDGF-receptor induced proliferation in 
pathological states such as restenosis and 
atherosclerosis.
My studies further demonstrate that both ln-5, as well 
as FN, is able to support cell proliferation in the 
absence of PDGF-stimulâtion, however the combination of 
ln-5 upregulation in the sites of injury and the 
release of PDGF and other growth factors indicate that 
more complex synergistic interactions exist that may 
drive the pathological phenotype of VSMC following 
vascular injury.
VSMC adhesion to ln-5
Ln-5 exerts its effects on cellular behaviors such as 
adhesion through receptor-mediated intracellular 
signaling pathways. The interaction of adherent cells 
with the ECM is mediated by integrin receptors, a 
family of transmembrane heterodimers that link the 
cytoskeleton to the ECM [35]. For example, ln-5 
regulates the static adhesion of bladder and intestinal 
epithelia, human foreskin, and breast epithelial cells
through a6p4 integrin receptors associated with 
hemidesmosomes [36 - 38].
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I therefore sought to determine the binding 
interactions that regulate VSMC ligation to ln-5, 
specifically determining the receptors responsible for 
integrin-mediated VSMC adhesion to ln-5. My results 
indicated that the a6pi integrin may be responsible for 
the initial VSMC adhesion to ln-5 and that the a6p4 
integrin complex may also mediate binding of VSMC to 
ln-5. Thus, the increased production of and 
alterations to VSMC adhesion on ln-5 may provide novel 
and interesting targets in the prevention of 
pathological processes associated with the arterial 
vasculature, such as restenosis following angioplasty.
VSMC migration on ln-5
The first stage of VSMC response after a lesion, such 
as that inflicted in angioplasty, is the formation of 
the neointima, characterized by VSMC proliferation and 
migration from the tunica media into what will become 
the neointima. To further understand the mechanisms 
that contribute to VSMC migration into the lumen, the 
first major event in vascular remodeling, I analyzed 
the relationship between the ECM and certain growth 
factors with respect to VSMC migration in vitro.
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My previous work described ln-5 expression by VSMC and 
further suggested that ln-5 is upregulated in response 
to platelet-derived growth factor (PDGF-BB), a potent 
chemoattractant and mitogen for VSMC that is released 
following injury, therefore, I hypothesized that ln-5 
may differentially affect the migration of VSMC and may 
serve to mediate the migratory response of VSMC to 
growth factors such as PDGF-BB.
I found that while other ECM molecules such as collagen 
IV, laminin-1, fibronectin, and vitronectin support 
haptotactic migration of VSMC, ln-5 does not. 
Furthermore, my studies indicate that EGF, bFGF, and 
TGF-pi, polypeptide growth factors also released after 
injury, do not stimulate chemotactic VSMC migration on 
ln-5 whereas PDGF-BB stimulation greatly enhanced VSMC 
migration on ln-5.
In order to determine the integrin receptors 
responsible for the In-5-directed migration of VSMC, I 
employed in vitro competition studies and found that 
pi-integrin subunit blockage reduced VSMC migration on 
ln-5 in a dose-dependent manner, even in the presence 
of PDGF-BB stimulation. These data support my 
hypothesis that ln-5 differentially affects the
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migration of VSMC and may serve to mediate the 
migratory response of VSMC to growth factors such as 
PDGF-BB. Additionally my data support the observation 
that VSMC migration on ln-5, in response to PDGF-BB, 
may be regulated by the pi-integrin subunit, thereby 
providing the mechanical link between ln-5 and the cell 
cytoskeleton that mediates the effects of exogenous 
chemotactic stimulants, such as PDGF-BB.
VSMC ERK1/ERK2 activation on ln-5
The accumulation of vascular smooth muscle cells (VSMC) 
in the intima is the result of both growth factor- 
directed migration and proliferation. Growth factor- 
directed VSMC migration is dependent upon both 
interaction with the extracellular matrix (ECM) through 
integrin receptors and on growth factor receptor 
activation. Growth factor receptor-activated pathways 
converge with integrin receptor-activated pathways, at 
least in part, through the mitogen-activated protein 
kinase (MAPK) pathway (Figure 3).
Many current theories hypothesize that PDGF released 
from platelets is primarily responsible for the initial 
VSMC stimulation, which in turn stimulates VSMC to 
synthesize and release PDGF [39]. This autocrine- or
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self-stimulated migration of VSMC may be the first 
major growth factor-mediated event known to influence 
cellular events such as VSMC phenotypic transformation, 
migration, and proliferation, at least in part, through 
the mitogen-activated protein kinase (MAPK) pathway 
[40, 41].
I hypothesized that ln-5 may affect the migration of 
VSMC and may serve to mediate the migratory response of 
VSMC to growth factors such as PDGF-BB. Furthermore, I 
postulated that PDGF-BB-stimulated MAPK activation is 
responsible for the increased migratory phenotype of 
VSMC on ln-5.
My results reveal that stimulation of VSMC with 
platelet-derived growth factor (PDGF-BB) reduced VSMC 
adhesion to ln-5 and concomitantly increased VSMC 
migration on ln-5 also revealing detectable increases 
in ERKl/2 activation. I also found that the inhibition 
of PDGF-BB-stimulated MAPK activation using PD98059, a 
specific inhibitor of MEKl and the MAPK cascade, 
decreased VSMC migration on ln-5 while increasing VSMC 
adhesion to ln-5.
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These results suggest that PDGF-BB-stimulated VSMC 
migration on ln-5 is at least partially dependent upon 
intracellular signaling through the MAPK signaling 
cascade and more specifically through ERK1/ERK2 
activation. Furthermore, PDGF-stimulated MAPK 
activation negatively regulates VSMC adhesion to ln-5 
and can be reversed by specific inhibitors to MAPK 
activation as well as by soluble plasma factors that 
reduce MAPK activation.
Implications of VSMC ln-5 expression
Many previous studies have demonstrated that growth 
factor-directed VSMC migration is dependent upon both 
interaction with the extracellular matrix (ECM) through 
integrin receptors and on growth factor receptor 
activation. In this study we identified expression of 
the a3, (33, and y2 chains of ln-5 in the layers of the 
aorta and pulmonary artery.
My results also demonstrated that ln-5 significantly 
altered the proliferation of VSMC in response to PDGF- 
BB, a potent mitogen and chemoattractant for VSMC. I 
observed that the a6pi, and the a6p4 integrin complex 
may be responsible VSMC adhesion to ln-5.
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In addition, I determined that ln-5 affected the 
migration of VSMC and may serve to mediate the 
migratory response of VSMC to growth factors such as 
PDGF-BB specifically through ERK1/ERK2 activation. 
Furthermore, PDGF-stimulated MAPK activation reduces 
VSMC adhesion to ln-5 and can be reversed by specific 
inhibitors to MAPK activation as well as by soluble 
plasma factors such as TGF-pi that reduce MAPK 
activation.
As ln-5 is involved in the enhanced migration of 
various cell types, the increased production and 
decreased adhesion of VSMC to ln-5 may provide a 
mechanism for the design of novel and interesting 
targets in the prevention of pathological processes 
associated with the arterial vasculature, such as 
restenosis following angioplasty. The use of anti­
oligonucleotide therapy and other site-specific 
negative regulators of ln-5 expression may provide 
additional methods to be used in the prevention of 
pathological processes associated with the arterial 
vasculature, such as restenosis.
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Figure 1. Laminin structure. Each laminin molecule is 
composed of three basic, non-identical subunits, an a- 
, p-, and y-subunit that assemble into a cross-like 
structure with one long and three short arms; the 
amino terminus of the a-, p-, and y- subunits 
separately form the three short arms, whereas the 
three chains fold together in a coiled-coil structure 
to form the length of the carboxy-terminal long arm.
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Laminin
isoform
a chain (3 chain y chain
1 1 1 1
2 2 1 1
3 1 2 1
4 2 2 1
5 3 3 2
6 3 1 1
7 3 2 1
8 4 1 1
9 4 2 1
10 5 1 1
11 5 2 1
Figure 2. Laminin isoforms. Different a., P, and y chain 
isomers combine to give rise to different heterotrimeric 
laminin isoforms that vary with respect to their tissue 
distribution and tissue-^specific functions.
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Figure 3. Vascular smooth muscle cell phenotype can be 
altered by integrin-receptor mediated activation as well 
as growth-factor receptor-mediated activation through the 
mitogen activated protein kinase (MAPK) pathway, a point 
of convergence between integrin signaling and growth 
factor receptor signaling (courtesy of cellsignal.com).
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C H A P T E R  2
NOVEL METHOD FOR IMMUNOHISTOCHEMICAL DETECTION 
OF LOW-LEVEL EXTRACELLULAR MATRIX MOLECULES
This chapter has been published in BioTechniques and is 
presented in the style of that journal. The complete 
citation is:
Kingsley, K., Carroll, K., Huff, J.L., and Plopper,
G.E. April 2001. Photobleaching of Arterial
Autofluorescence for Immunofluorescence Applications.
BioTechniques 30: pp. 7 94 - 7 97.
Abstract
Immunohistochemical localization of low-level antigens 
in the arterial vasculature is complicated by the 
presence of complex molecules such as collagen, 
elastin, cholesterol and fluorescent lipids that 
exhibit autofluorescence over a wide spectrum of 
wavelengths. UV-irradiation of arterial vasculature 
has remained ineffective in preparing samples for 
immunofluorescent staining due to the recovery of the 
endogenous fluorescence within a short time following 
treatment. Therefore, we sought to further enhance the
37
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signal -to- noise ratio in arteries by optimizing 
photobleaching of this tissue. We report here that the 
use of filtered sunlight significantly reduces arterial 
autofluorescence compared to standard UV shortwave and 
longwave irradiation and maintains multiple antigen 
epitopes suitable for immunohistochemical analysis. 
Using this method, we localized low-level laminin-5 
isoform expression in situ, which was previously 
indistinguishable from endogenous autofluorescence.
Introduction (cunendment)
The goal of this study was to determine temporal and 
spatial patterns of ln-5 expression in non-epithelial 
tissues. Because ln-5 plays a key role in controlling 
the growth and movement of epithelial cells, it is 
possible that it may play a similar role in mesoderm 
tissue, beginning in embryonic development and 
continuing in neonatal and adult tissues.
Because previous expression studies have failed to 
detect the ln-5 isoform in non-epithelial tissues, it 
is likely that ln-5, if expressed, is found in very low 
abundance in these tissues. Standard
immunohistochemical techniques are often not sensitive 
enough for the detection of low-level protein
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expression in situ. This was also true in the case of 
non-epithelial expression of ln-5.
Introduction
Endogenous fluorescent molecules containing multiple 
tissue fluorophores complicate the use of 
immunofluorescence labeling in tissues such as the 
arterial vasculature, especially when attempts are made 
to localize low-abundance antigens in this tissue. In 
addition to elastin and collagen, cholesterol, 
fluorescent lipids, and other compounds further 
complicate spectral analysis of this tissue [2]. 
Enzymatic amplification of the specific fluorescent 
signal above background is one means of overcoming this 
problem. For example the use of a fluorogenic 
phosphatase substrate, 2-(5'-chloro-2'- 
phosphoryloxyphenyl)-6-chloro-4-[3H]-quinazolinone, 
otherwise known as the ELF-substrate [7], alone has 
improved sensitivity in several circumstances.
The ELF-substrate produces a photostable precipitate 
upon dephosphorylation that amplifies antibody 
detection of low-abundance antigens in 
immunohistochemical analyses. This dephosphorylation 
is accomplished by alkaline-phosphatase conjugation to
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secondary antibodies via a steptavidin-biotin bridge. 
The ELF technique has been used to successfully 
localize low-level expression of (3-galactosidase fusion 
proteins in yeast, overlapping gene expression regions 
in mouse embryos, and adult zebrafish retinal tissue 
antigens [1,4,6]. Although ELF alone significantly 
improves sensitivity in several tissues, its effect 
cannot overcome arterial autofluorescence. Hence, we 
tested several different conditions to determine which 
had the greatest reduction in tissue arterial 
autofluorescence.
Using defined conditions of filtered sunlight to 
decrease autofluorescence in conjunction with signal 
amplification using the ELF substrate, we observed low- 
level antigen localization that was distinguishable 
from endogenous autofluorescence and that the antigen 
epitopes are recognized by specific monoclonal 
antibodies. Using specific monoclonal antibodies we 
demonstrated the conservation of multiple antigenic 
epitopes following this treatment. These data provide 
an effective technique to increase the sensitivity of 
immunofluorescence staining by the reduction of 
background interference.
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Materials and Sfethods
Tissue preparation.
Adult aortic sections for initial studies were obtained 
from Roy C. Smith, (St. Elizabeth's Medical Center, 
Boston, MA, USA). All subsequent animals were 
maintained by Animal Care Facilities at the University 
of Nevada, Las Vegas (UNLV) according to protocol R701- 
1297-136: Developmental Studies in Rats and Mice.
Adult rat tissues were fixed at 4° C for 24 hours in 
each of three successive paraformaldehyde solutions (4% 
w/v) containing 5%, 10% and 15% sucrose, respectively. 
Specimens were frozen in Miles Tissue-TEK OCT 4583 
embedding medium using standard cryomolds and liquid 
freon. Tissue sections (8(J.m thick) were cut using a 
Microm Cryostat HM 505E (Microm GmbH: Walldorf,
Germany) and adhered to poly-L-lysine (0.8 mg/mL)- 
coated glass slides for photobleaching and staining.
Photobleaching.
Control tissue sections were maintained at 25° C, 
without direct contact to solar exposure. UV- 
irradiated tissues were maintained at 25° C, 5 cm from 
a UV-longwave (365 nm) or UV-shortwave (254 nm) 
illuminator. For treatment with filtered sunlight, 
tissues were maintained at 27° C in a greenhouse at
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constant oxygen (20%) and carbon dioxide (5%) 
concentrations. Each day constitutes 11.98 - 12.24 
hours of solar exposure.
Solar filter.
Greenhouse glass consists of two panes with special 
coating. The inner surface of the outermost pane is 
coated with darkglass, isolated to have a better k- 
value that decreases heat loss. The inner pane is 
coated with an oxid-layer (tinoxid) that influences the 
penetration of radiation. This system has a light 
transmission above 50 - 55% for the visible part of the 
spectrum (380 - 780 nm) and 30 - 32% transmission in 
the UV-spectrum (10 - 400 nm).
Antibodies.
Primary monoclonal antibody (mAb) to all three subunits 
of laminin-5 (CM6: a-3 subunit; FM3 : (3-3 subunit; TRl, y- 
2 subunit) were generously provided by Desmos, Inc.
(San Diego, CA, USA). Goat anti-rat elastin polyclonal 
antibody (pAb.) 4060-1104 and goat anti-rat collagen 
type 1 pAb. 2150-1908 were obtained from Biogenesis 
(Kingston, NH, USA). Secondary antibodies were biotin- 
labeled donkey anti-goat (H+L) conjugate RDI-705065147 
obtained from Research Diagnostics (Flanders, NJ, USA)
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and biotin-SP goat anti-mouse IgG (H+L) conjugate B2763 
(2 mg/mL) obtained from Molecular Probes (Eugene, OR, 
USA) .
Immunohistochemistry.
Tissues were prepared according to Molecular Probes 
ELF-97 Immunohistochemistry Protocol, MP 06600. All 
reactions were performed in a humidified chamber at 25° 
C. Tissue sections were incubated with blocking buffer 
(30 mM Tris-HCl, 150 mM NaCl, 1.0% bovine serum 
albumin, 0.5% Triton X-100, pH 7.5), followed by 
incubation with primary antibody (1:500 dilution in 
wash buffer : 30 mM Tris-HCl, 150 mM NaCl, pH 7.5) . 
Subsequent incubations with biotinylated secondary 
antibody (1:1000 dilution in wash buffer), streptavidin 
(1:250 dilution in wash buffer) and ELF-97 Substrate 
Reagent (1:20 dilution with ELF-97 Immunohistochemical 
Reaction Buffer) were performed after serial tissue 
incubations with wash buffer. The reaction was 
arrested using stop buffer (25 mM EDTA, 1.0 mM 
levamisole, 0.05% Triton X-100 in IX PBS, pH 8.0) and 
mounted in ELF-97 Immunohistochemical Mounting Medium 
from Molecular Probes.
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Microscopy.
Stained tissues were visualized using a Leica DM LB 
immunofluorescence microscope (Leica GmbH: Wetzlar, 
Germany) equipped with 4' , 6-diamidino-2-phenylindole, 
dihydrochloride (DAPI) long-pass and fluorescein-5- 
isothiocyanate (FITC) filter sets. ELF-substrate 
excitation and emission wavelengths are 360 and 535 +/- 
18 nm, respectively. Images were collected using SPOT 
Diagnostic digital imaging photographic equipment in 
bright and darkfield. UV band pass (BP) excitation 
filter 340 - 380 nm and long pass (LP) suppression 
filter (425 nm), were used for the collection of DAPI 
images; 450 - 490 BP excitation filter and 515 LP 
suppression filter were used for the collection of FITC 
images; 515 — 560 BP excitation filter and 590 LP 
suppression filter were used for the collection of 
rhodamine images. Quantitation of relative 
autofluorescence was measured with Adobe Photoshop 
imaging software using Image analysis.
Results
To remove the primary autofluorescence of endogenous 
molecules, I performed multiple photobleaching 
techniques to determine a method of reducing tissue 
fluorescence. Prolonged irradiation of arterial tissue
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with UV-long pass (Figure le - h) and UV-short pass 
(Figure li - 1) filters reduced the intensity of 
autofluorescence only marginally, whereas exposure to 
filtered solar radiation (Figure Im - p) diminished the 
endogenous autofluorescence of arterial vascular tissue 
significantly compared to UV-treated and control 
(Figure la - d) tissue sections.
Control tissues autofluorescence experienced nominal 
photobleaching from the photomicroscopy procedure by 
approximately one-fifth at 425 nm, 515 nm and 590 nm 
(Figure 2a). UV-long pass did not reduce 
autofluorescence emissions at 425 nm but did reduce 
emissions at 515 nm, 58% at 515 nm and by 9% at 590 nm 
(Figure 2c). UV shortwave reduced emissions at 425 nm 
by 13%, by 30% at 515 nm and by 25% at 590 nm (Figure 
2b). Solar-treated tissue sections experienced the 
greatest overall level of irreversible photobleaching, 
reducing emissions by 73% and 77% at 425 nm and 515 nm 
respectively, but did not reduce emissions at 590 nm. 
(Figure 2d).
Epitopes for collagen I, elastin and laminin-5 were 
resistant to photodegradation and photochemical 
oxidation damage during filtered-solar radiation
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exposure. Monoclonal antibodies to all three chains of 
the laminin-5 isoform (Figure 3d and e) and polyclonal 
antibodies to collagen I (Figure 3f) and elastin 
(Figure 3c) bound their ligands with sufficient 
affinity for immunohistochemical applications. The 
reduction of endogenous autofluorescence (Figure 3a) 
and the preservation of these antigens allowed for the 
detection of these proteins by both traditional and 
enzymatically enhanced variations of 
immunohistochemistry.
Discussion
Our results suggest that filtered, solar radiation is a 
simple and effective method for reducing arterial 
tissue autofluorescence. The effect of filtered, solar 
radiation on emissions at 425 nm and 515 nm are at 
least 20% better than both UV-shortwave and UV-longwave 
radiation. We observed an 84-100% recovery of 
autofluorescence 10 days after conventional 
photobleaching with UV-longwave and UV-shortwave 
filters. In contrast, we showed that a 5-day exposure 
to filtered sunlight significantly reduced 
autofluorescence, which does not increase 10 days after 
treatment cessation, remaining at 27% (425 nm), and 23%
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(515 nm) of the original signal after the 10-day 
recovery period.
The photobleaching of these compounds may be caused by 
a chemical change of the excited fluorophore into a 
species that cannot fluoresce because of the inability 
to further absorb excitation photons. Thus sustained, 
filtered-solar radiation may provide the multiple 
wavelengths required to yield photochemical alterations 
of these complex and varied molecules to either a lower 
or absent fluorescence state, a result not typically 
accomplished by traditional laser and UV radiation 
techniques.
The difference in autofluorescence recovery between 
these treatments was likely due to the relative 
reduction of autofluorescent compounds by neighboring 
electron donors in the tissue. Exposure to filtered 
sunlight provides excitation over a broader spectrum of 
wavelengths than either UV-long or UV-short bands, and 
thus may cause a more effective oxidation of 
fluorescent compounds and neighboring molecules. This 
is reflected by the rate of recovery of 
autofluorescence following photobleaching: Ten days
after a five day photobleaching period.
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autofluorescence at 425 nm returned to 100% and 84% of 
pre-bleached levels in tissues exposed to UV-short and 
UV-longwave spectra respectively, while no recovery of 
autofluorescence was observed in tissues exposed to 
filtered sunlight after the same time course.
Photobleaching may affect each fluorescent compound of 
the arterial wall differently. Complex autofluorescent 
molecules such as collagen and elastin contain more 
than one fluorophore that may photobleach at different 
wavelengths [3,5]. The intensity of collagen 
autofluorescence (515 nm) decreased significantly 
(Figure Ic, g, k, and o) more than that of elastin 
autofluorescence (425 and 515 nm) (Figure lb, f, j, and 
n) suggesting photobleaching does affects each compound 
of the arterial wall to different extents.
In addition, our results also show that despite any 
effects solar radiation induces in the autofluorescence 
of the sample, multiple binding-epitopes are preserved. 
This allows for more sensitive immunohistochemical 
staining for non-abundant proteins based on the fact 
that solar exposed samples are both lower in 
background, and have uncompromised epitopes.
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This method indicates there are variations in the time 
and wavelength-dependence of fluorescence decay among 
fluorescent molecules in this tissue. Given these 
considerations, a photobleaching method appropriate for 
the tissue and immunofluorescent chromophore can be 
determined; double and triple-labeling
immunohistochemistry experiments involving two or more 
chromophores may benefit from this method of tissue 
preparation. These results can be replicated in a 
variety of greenhouse glass-enclosed environments based 
upon the need for autofluorescence reduction across 
multiple wavelengths. Use of Rhodamine may not require 
photobleaching in this tissue whereas use of DAPI and 
FITC may require intense methods of photobleaching.
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CHARACTERIZATION OF LAMININ-5 EXPRESSION 
IN DEVELOPING BONE AND CARTILAGE
Abstract
Laminin-5 (ln-5) is a heterotrimeric adhesion molecule 
secreted in the basement membrane of subsets of various 
epithelial tissues that include skin, prostate, and 
breast. In this study, I sought to determine temporal 
and spatial patterns of ln-5 expression in non- 
epithelial tissues. Using an enzyme-linked 
immunofluorescence amplification system, I observed In- 
5 expression in previously undocumented sites including 
the aorta, pulmonary arteries, bone, and cartilage. In 
situ hybridization using digoxigenin-labeled probes 
specific for each chain localized ln-5 expression to 
developing chondrocytes, and adult osteoclasts and 
fibrocartilage of the rib. These findings bolster the 
hypothesis that ln-5 is expressed in these tissues.
56
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Introduction
Cells from the developing embryo synthesize and secrete 
many proteins that constitute the extracellular matrix 
(ECM), which plays several key roles in the development 
of vertebrate organisms. In some cases the ECM serves 
to separate two adjacent groups of cells to preclude 
any interactions between them, while in other cases the 
ECM may serve as a substrate that induces the migration 
or differentiation of specific cell types [1].
The ECM of most tissues is comprised of three major 
constituents: collagen, proteoglycans, and
glycoproteins. Collagen is a family of secreted 
proteins that provides the major structural support of 
almost every animal organ, constituting nearly half of 
the total body protein of most animals [2]. 
Proteoglycans are specific types of ECM glycoproteins 
where the interconnection of protein and carbohydrates 
form a web-like matrix, which mediates both the 
consistency of the matrix and the interactions of the 
cells contained within it. Finally, ECM glycoproteins 
include a variety of specialized molecules such as 
fibronectin and laminin.
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Ln-5 is a laminin isoform composed of three subunits 
designated a3, (33, and y2. Expression of the y2 and P3 
subunits have been found only in ln-5 while the a3 
subunit is found in both ln-6 and ln-7. Ln-5 is 
expressed in distinct temporal and spatial patterns in 
developing epithelial tissues and influences tissue 
compartmentalization and cellular phenotypes from early 
embryonic development onward [3]. To date, the 
expression of ln-5 in non-epithelial tissues has been 
unreported. In this study I will demonstrate the 
spatial and temporal regulation of ln-5 isoform 
expression in the developing tissues of the rib.
During skeletogenesis, the pattern of ECM components 
produced by the differentiating cell types, and 
consequently the organization of the ECM molecules, 
changes to provide the template of the future skeleton 
[4]. The skeleton is comprised of two main tissue 
types, cartilage and bone. These two tissue types can 
be further subdivided into individual cell types; the 
chondrocyte in cartilage, the osteoblast and osteoclast 
in bone [5], as shown in Table 1.
These cell types play an important role in both major 
modes of bone formation, intramembranous ossification.
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which is involved in the formation of the flat bones of 
the skull, and endochrondral ossification, which is 
involved in the formation of the vertebrae, ribs, 
pelvis, and the extremities. The formation of rib 
begins with a cartilaginous model of the bone formed of 
cartilage secreted from early stage chondrocytes. The 
ECM-rich outer mesenchyme sheath of this progenitor 
bone gives rise to the periosteum and is the source of 
invading capillary beds that ultimately provide the 
components necessary for bone maturation.
The invasion of capillary beds through the dense ECM- 
rich mesenchyme sheath is the first step in a cascade 
that forms the cell layers associated with late-stage 
bone development. During this process, the 
chondrocytes proximal to the capillary beds enter a 
stage of rapid cell proliferation and form new layers 
of cells due to the influx of oxygen and nutrients.
As these cells continue to proliferate they form a new 
layer which is further separated from the oxygen and 
glucose source and these cells enter a phase of 
hypertrophy or cell enlargement. This hypertrophy is 
caused by the swelling and release of intracellular 
calcium stores, which they are no longer able to retain
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in this layer of energy-deficient anaerobic 
environmental gradient. This hypertrophy and 
subsequent calcium release starts the calcification of 
the surrounding ECM. As a final step, osteoblasts line 
up along the calcified matrix and deposit additional 
bone matrix. This bone matrix can later be modified by 
the bone remodeling class of cells known as 
osteoclasts, which enter the bone through capillaries 
to dissolve inorganic and protein portions of the bone 
matrix, an important step prior to the formation of 
bone marrow.
The secretion of a specialized ECM is one of the 
earliest functional changes in bone development and may 
be crucial for the establishment of specific 
microenvironments that drive differentiation in these 
cell types. This study will provide the first 
conclusive evidence of novel laminin-5 isoform 
expression in the developing rib during mid- and late- 
stage bone development, a critical period of 
interactions between cells and the ECM.
Materials and Ifethods
Tissue preparation.
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Tissues were fixed and permeabilized according to 
protocol as previously described [6]. Adult animals 
were maintained by Animal Care Facilities at the 
University of Nevada, Las Vegas (UNLV) according to 
protocol R701-1297-136: Developmental Studies in Rats 
and Mice. Adult rat tissues were fixed at 4° C for 24 
hours in each of three successive paraformaldehyde 
solutions (4% w/v) containing 5%, 10% and 15% sucrose,
respectively. Specimens were frozen in Miles Tissue- 
TEK OCT 4583 embedding medium using standard cryomolds 
and liquid freon. Tissue sections (8 fj.m thick) were 
cut using a Microm Cryostat HM 505E (Microm GmbH: 
Walldorf, Germany) and adhered to poly-L-lysine (0.8 
mg/mL)-coated glass slides for photobleaching and 
staining.
Photobleaching.
Treatment with filtered sunlight : tissues were 
maintained at 27° C in a tinoxid-filter greenhouse at 
constant oxygen (20%) and carbon dioxide (5%) 
concentrations as previously described [7].
Antibodies.
Primary monoclonal antibody (mAb.) to all three 
subunits of laminin-5 (CM6:a-3 subunit; FM3: p-3
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subunit; TRI, y-2 subunit) were generously provided by 
Desmos, Inc. (San Diego, CA, USA). Secondary 
antibodies were biotin-SP goat anti-mouse IgG (H+L) 
conjugate B2763 (2 mg/mL) obtained from Molecular 
Probes (Eugene, OR, USA).
Immunohistochemistry.
Tissues were prepared according to Molecular Probes 
ELF-97 Immunohistochemistry Protocol, MP 06600. All 
reactions were performed in a humidified chamber at 25° 
C. Tissue sections were incubated with blocking buffer 
(30 mM Tris-HCl, 150 mM NaCl, 1.0% bovine serum 
albumin, 0.5% Triton X-100, pH 7.5), followed by 
incubation with primary antibody (1:500 dilution in 
wash buffer: 30 mM Tris-HCl, 150 mM NaCl, pH 7.5). 
Subsequent incubations with biotinylated secondary 
antibody (1:1000 dilution in wash buffer), streptavidin 
(1:250 dilution in wash buffer) and ELF-97 Substrate 
Reagent (1:20 dilution with ELF-97 Immunohistochemical 
Reaction Buffer) were performed after serial tissue 
incubations with wash buffer. The reaction was 
arrested using stop buffer (25 mM EDTA, 1.0 mM 
levamisole, 0.05% Triton X-100 in IX PBS, pH 8.0) and 
mounted in ELF-97 Immunohistochemical Mounting Medium 
from Molecular Probes.
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Microscopy.
Stained tissues were visualized using a Leica DM LB 
immunofluorescence microscope (Leica GmbH: Wetzlar, 
Germany) equipped with 4',6-diamidino-2-phenylindole, 
dihydrochloride (DAPI) long-pass and fluorescein-5- 
isothiocyanate (FITC) filter sets. ELF-substrate 
excitation and emission wavelengths are 360 and 535 +/- 
18 nm, respectively. Images were collected using SPOT 
Diagnostic digital imaging photographic equipment in 
bright and darkfield. UV band pass (BP) excitation 
filter 340 - 380 nm and long pass (LP) suppression 
filter (425 nm), were used for the collection of DAPI 
images; 450 - 490 BP excitation filter and 515 LP 
suppression filter were used for the collection of FITC 
images; 515 - 560 BP excitation filter and 590 LP 
suppression filter were used for the collection of 
rhodamine images.
Results
Chondrocytes and embryonic cartilage.
I confirmed several previously published sites of ln-5 
expression in the developing and neonatal rat using 
immunohistochemistry. In addition to these sites, I
identified expression of the a3, (53, and y2 chains in
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
64
the developing chondrocytes and areas of fibrocartilage 
matrix production in the rib, beginning at embryonic 
day 14 post coitus (p.c.) (Figure 1) at a stage when 
the chondrocytes are extremely proliferative and are 
arranged compactly [8].
I found that this restricted expression is first 
detectable in the interior of the mesenchyme sheath 
surrounding the cartilaginous rib progenitor at day 14 
p.c. This expression remains restricted to the 
interior of the mesenchyme and increases in both 
intensity and extent at day 16 p.c. and covers what 
appears to be the entire width of the primitive 
mesenchyme at day 18 p.c.
This expression is sustained and persistent in both 
neonates and adults. In neonatal and adult animals, 
however, this expression appears to encompass the 
periosteum entirely and is evident proximal to 
chondrocytes trapped in the osteoid matrix (Figure 2). 
Longitudinal cross sections of the rib reveal that the 
isoforms of ln-5 are expressed across the dense 
fibrocartilage comprising the periosteum in sharp 
contrast to the restricted, interior expression 
patterns seen in the fetus.
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Osteoclasts
Ln-5 expression is also detected in the secreted matrix 
immediately surrounding osteoclasts, the bone 
remodeling class of multinucleated cells (Figure 3). 
This expression appears to be transient and is only 
detectable in the immediate vicinity of the osteoclast 
itself and not in the remodeled areas of interior bone 
matrix.
Discussion
In this study I provide evidence for the presence of 
the laminin-5 isoform in bone and cartilage during 
fetal rat development. A strong immunofluorescence 
reaction was precipitated in the developing cartilage 
of the rib at day 16 p.c., mainly restricted to the 
interior of the mesenchyme sheath surrounding the 
cartilaginous shaft. I previously reported that the 
use of filtered sunlight significantly reduces ECM 
autofluorescence compared to standard UV short and 
long-wave irradiation and that this method maintains 
multiple antigen epitopes suitable for 
immunohistochemical analysis [7].
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It is from this mesenchyme sheath that the periosteum 
will be formed, thus creating a matrix boundary from 
which the invading capillary beds will form [9]. It is 
my hypothesis that ln-5 may be expressed prior to the 
formation of vascular capillary beds.
Other recent studies have localized the laminin-1 
isoform in these sections of fetal cartilage, most 
prominently in mature chondrocytes appearing in the 
presumptive secondary ossification zone, an area rich 
in vascular formations [10]. Strong pericellular 
staining was observed in the vicinity of invading 
capillary sprouts in this zone, further implication 
laminin-1 in this process.
Chondrocytes in the hypertrophic zones further from the 
vascular bed formations, however, did not exhibit 
detectable expression patterns using any of the several 
polyclonal antibodies against the E8 fragment of 
laminin-1. Pericellular laminin staining was 
consistently seen in the upper zone (three to ten cell 
layers from the articular surface), an area rich in 
capillary and vascular beds, but not in the deep zone 
of adult tissues which is devoid of these vascular
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structures. These observations are consistent with my 
observations of ln-5 expression.
My observation is that ln-5 expression in the neonate 
and adult appears to encompass the periosteum entirely 
and is evident proximal to chondrocytes in the osteoid 
matrix in areas of strong secondary ossification. This 
suggests that ln-5 may be involved in the preparation 
for vascular sprouts invasion in the fetal cartilage or 
on the chondrocyte phenotype associated with this 
invasion.
My data also suggest that ln-5 is not expressed in 
hypertrophic cartilage. Ln-5 expression therefore 
correlates well with expression of laminin isoforms in 
this tissue. Other laminin isoforms such as laminin-1 
are not expressed by immature or dedifferentiated 
chondrocytes in perichondrial and hypertrophic 
cartilage, but are restricted to proliferating, 
vascularized zones. My observation that ln-5 is also 
not expressed in these hypertrophic zones but in the 
vascularized regions provides further support that ln-5 
expression, along with other laminin isoforms, may be 
involved in the formation of vascular invaginations 
into the cartilaginous tissue of developing rib.
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Osteoclast expression
Osteoclasts are specialized cells that enter the bone 
through blood vessels and capillaries and dissolve the 
inorganic and protein portions of the bone matrix in a 
process known as bone resorption [11]. Osteoclasts 
achieve this function through the secretion of ions, 
thus acidifying and solubilizing the bone matrix. 
Problems associated with reduced or impaired osteoclast 
function include osteopetrosis, a condition marked by 
an increase in bone mass. The absence or defective 
function of osteoclasts is responsible for this lack of 
bone resorption and the clinical manifestations 
associated with it.
The immunohistochemical detection of ln-5 in the 
subcellular and immediately extracellular domains of 
the osteoclast but not in the cavity or areas of bone 
resorption present an interesting dilemma. It is 
possible that ln-5 is being used by osteoclasts as a 
migratory substrate to facilitate the bone resorption 
process. A number of other studies have demonstrated 
that ln-5 is used as a migratory substrate in other 
cell lines such as endothelial cells, kératinocytes and 
invasive tumors [12 - 14].
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It is also possible that ln-5 may act as a secreted 
protein that may control osteoclast differentiation. 
Another recently discovered secreted protein, 
osteoprotegrin (OPG), is necessary for osteoclast 
precursors to differentiate into functional osteoclasts 
[15]. OPG-deficient mice that express no soluble OPG 
factor develop osteoclast precursors but fail to 
differentiate into functional osteoclasts, suggesting 
that OPG acts at one of the last stages of osteoclast 
differentiation. It is therefore possible that OPG in 
its soluble form may bind to the secreted matrix, 
inducing or maintaining the differentiation state of 
the osteoclast. In this scenario, ln-5 may act as a 
docking molecule or co-factor in the differentiation 
cascade involving OPG secretion.
The role of laminin isoforms in the development and 
formation of bone and cartilage is in the initial 
stages of investigation. Many recent studies involving 
laminin-1 expression as an effector controlling 
chondrocyte and osteoblast differentiation have led to 
my hypothesis that other laminin isoforms may be 
playing similar roles in development. The expression 
of ln-5 in restricted areas of the developing bone and
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rib, primarily in the vascular invasive areas located 
at the interior of the mesenchyme, may lead to future 
studies investigating the role of ln-5 in the late 
stages of cartilage differentiation and subsequent 
endochondral ossification.
The identification of ln-5 in subcellular and proximal 
areas of osteoclast activity further raise the 
possibility that ln-5 may be used by osteoclasts as 
either a migratory substrate or may act as a secreted 
protein that may control osteoclast differentiation.
The study of In-5-deficient models possible and may 
lead to further refinement of the role of ln-5 in the 
development of bone and cartilage.
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Figure 1. Immunohistochemical localization of ln-5 
expression in the developing rat embryo. Early fetal rats 
stained for the ot3, p3, and y2 subunits after photobleaching 
and tissue treatment, using CM6, FM3, and TRl MAb, 
respectively. Each horizontal row shows the expression by 
developmental stage (day 14 p.c., day 16 p.c., day 18 p.c.). 
Each vertical column shows the expression by subunit- 
spoecific staining (a3 subunit in the first column, P3 
subunit in the second column, and y2 in the last column) . 
Extremely low-level pattern expression is seen in the early 
developing rib at day 14 p.c. (a - c), which is distinct and 
restricted to the interior of the mesenchyme sheath at day 16 
p.c. (d - f), and covers the entire width of the primitive 
mesenchyme at day 18 p.c. in areas which may serve as the 
center for capillary bed invasion (g - i).
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Figure 2. Immunohistochemical localization of 
ln-5 expression in the neonate and adult. In 
neonatal and adult animals, ln-5 expression 
appears to encompass the periosteum (arrow) 
entirely as visualized by y2 subunit staining 
(top) and is evident proximal to chondrocytes 
trapped in the osteoid matrix. Longitudinal 
cross sections of the rib reveal ln-5 expressed 
across the dense fibrocartilage (arrow) 
comprising the mature periosteum (bottom).
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
m
Figure 3. Ln-5 expression is detected 
in the secreted matrix immediately 
surrounding osteoclasts. ELF-staining 
using TRl, a monoclonal antibody for 
the y2 subunit revealed ln-5 expression.
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C H A P T E R  4
REGULATION OF VASCULAR SMOOTH MUSCLE CELL LAMININ-5 
EXPRESSION AND ADHESION BY PLATELET-DERIVED 
GROWTH FACTOR STIMULATION
This chapter has been submitted for publication to Cell 
Communication and Adhesion and is presented in the 
style of that journal. The complete citation is:
Karl Kingsley, William Rust, Janice L. Huff, Kilpatrick 
Carroll, Autumn Martinez, and George E. Plopper. 
(submitted July 2001) Regulation of vascular smooth 
muscle cell laminin-5 expression and adhesion by 
platelet-derived growth factor (PDGF) stimulation.
Cell Communication and Adhesion.
Abstract
VSMC migration and subsequent proliferation are events 
that are central to the formation of restenosis after 
injury, produced in response to an array of growth 
factors and extracellular matrix (ECM) proteins 
secreted locally at the sites of vascular remodeling. 
Using an enzyme-linked immunofluorescence amplification 
system and a newly developed photobleaching treatment,
I observed the ECM glycoprotein laminin-5 expressed in
78
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previously undocumented sites which include the aorta 
and pulmonary arteries. I hypothesized that vascular 
smooth muscle cells (VSMC) in the arterial vasculature 
express ln-5 and provide support using
immunofluorescence microscopy, western blot, and RT-PCR 
analysis. Furthermore, I determined that the a6pi and
a6p4 integrin complex are responsible for the initial 
VSMC adhesion to ln-5. I observed that ln-5 expression 
is upregulated by growth factors in vitro and that 
PDGF-BB stimulation reduced VSMC adhesion to ln-5 and 
increased ERKl/2 activation. I also found that the 
inhibition of PDGF-BB-stimulated MARK activation using 
PD98059, a specific inhibitor of MEKl and the MAPK 
cascade, increased VSMC adhesion to ln-5. Based upon 
these observations I postulated that PDGF-stimulated 
MAPK activation negatively regulates VSMC adhesion to 
ln-5 and can be reversed by specific inhibitors to MAPK 
activation. As ln-5 is involved in the enhanced 
migration of other cell types, the increased production 
of and decreased adhesion to ln-5 may provide one 
mechanism for the prevention of pathological processes 
associated with the arterial vasculature, such as 
restenosis following angioplasty.
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Introduction
Atherosclerosis is one of the leading causes of death 
in the United States [1]. Angioplasty is often useful 
for treatment of localized atherosclerotic obstructions 
and is performed on the scale of 300,000 or more per 
year in the United States alone [2], The long-term 
success of angioplasty treatment has been limited by 
reocclusion that occurs due to the erosion of the 
endothelium during the angioplasty procedure, and by 
the development of intimai hyperplasia (restenosis) in 
the area of the treated lesion in up to 50% of these 
procedures [3] .
Two major events contribute to restenosis, or the 
remodeling of the arterial vasculature, following 
injury. The first event is the migration of 
proliferating VSMC from the media of the vessel wall 
into the vessel lumen, contributing to the initial 
formation of a neointima. The second event is the 
subsequent proliferation of neointimal VSMCs, which 
leads to thickening of the neointima and to further 
occlusion. Both VSMC migration and the subsequent 
proliferation are events that are central to the 
formation of restenosis after injury, produced in 
response to an array of growth factors and
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extracellular matrix (ECM) proteins secreted locally at 
the sites of vascular remodeling [4].
Each phase is the cumulative response of VSMC to a 
complex network of stimuli that include loss of cell­
cell interactions, altered ECM deposition and 
secretion, and the localized release of growth factors. 
The loss of the integrity of the basement membrane and 
the subsequent exposure to cytokines and upregulated 
ECM, produced by both endothelial cells and other 
VSMCs, may provide the signals that transform the 
contractile VSMC phenotype to the proliferative and 
migratory phenotype induced following injury. ECM 
proteins are known to mediate both the proliferative 
and migratory phenotype of VSMC in pathological states 
such as atherosclerosis and restenosis [5].
One such set of soluble ECM glycoproteins are the 
laminin (In) family, which are required for structural 
integrity and development in many tissues. Each 
laminin molecule is composed of three non-identical 
subunits, an a-, p-, and y-subunit, that share homology 
and assemble into a cross-like structure with one long 
and three short arms [6]. Of the multiple laminin 
isoforms, ln-5 is composed of three subunits designated
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CÛ), P3, and y2. Expression of the y2 and P3 subunit 
have only been found in ln-5, while the a3 subunit is 
found in both ln-6 and In—7.
Ln-5 is abundantly expressed in distinct temporal and 
spatial patterns in developing epithelial tissues and 
influences tissue compartmentalization and cellular 
phenotypes from early embryonic development onward [7]. 
These tissues include the oral, nasal and olfactory 
epithelium, intestine and stomach, bronchi and 
bronchioli, and breast [8 - 12]. In these tissues ln-5 
has been shown to mediate growth, morphogenesis, and 
more importantly, wound healing [13 - 15].
Ln-5 is expressed in the basement membrane of 
epithelial tissues, however, the expression of ln-5 in 
non-epithelial tissues has been unreported to date. 
Because ln-5 plays a key role in controlling the growth 
and movement of epithelial cells, it is possible that 
it may play a similar role in mesoderm tissue, 
beginning in embryonic development and continuing into 
neonatal and adult tissues. We now know that ECM 
proteins such as fibronectin and In are able to mediate 
the proliferative and migratory phenotype of arterial 
smooth muscle cells in vivo and in vitro, but because
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previous expression studies have failed to detect the 
ln-5 isoform in non-epithelial tissues, it is likely 
that ln-5, if expressed, is found only in very low 
abundance [16, 17].
Using an enzyme-linked immunofluorescence amplification 
system and a newly developed photobleaching treatment,
I observed low-level ln-5 expression in previously 
undocumented sites including the aorta and pulmonary 
arteries. Standard immunohistochemical techniques are 
often not sensitive enough for the detection of low- 
level protein expression in situ. This was also true 
in the case of non-epithelial expression of ln-5.
Based on my in vivo observations I hypothesized that 
VSMC in the arterial vasculature express ln-5. 
Immunofluorescence microscopy, western blot analysis, 
and RT-PCR provided further support of my initial 
hypothesis that the ln-5 isoform is expressed in 
vascular smooth muscle tissue.
The interaction of adherent cells with the ECM is 
mediated by integrin receptors, a family of 
transmembrane heterodimers that link the cytoskeleton 
to the ECM [18]. Ln-5 exerts its effects on cellular 
behaviors such as adhesion through these receptor-
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mediated intracellular signaling pathways. For example, 
ln-5 regulates the static adhesion of bladder and 
intestinal epithelia, human foreskin, and breast 
epithelial cells through a6p4 integrin receptors 
associated with hemidesmosomes [19 - 21].
I therefore sought to determine the binding 
interactions that regulate VSMC ligation to ln-5, 
specifically determining the receptors responsible for 
integrin-mediated VSMC adhesion to ln-5. My results
indicate that the a6pi integrin and the a6p4 integrin 
complex mediate the initial binding of VSMC to ln-5.
The accumulation of vascular smooth muscle cells (VSMC) 
in the intima is the result of both growth factor- 
directed migration and proliferation. Growth factor- 
directed VSMC migration is dependent upon both 
interaction with the ECM through integrin receptors and 
by growth factor receptor activation. Growth factor 
receptor-activated pathways converge with integrin 
receptor-activated pathways, in part, through the 
mitogen-activated protein kinase (MAPK) pathway 
[22,23] .
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Many current theories hypothesize that platelet-derived 
growth factor (PDGF) released from platelets is 
primarily responsible for the initial VSMC stimulation, 
which in turn stimulates VSMC to synthesize and release 
PDGF [24]. This self-stimulated or autocrine-induced 
migration of VSMC may be the first major growth factor- 
mediated event recognized to influence cellular events 
such as the VSMC phenotypic transformation, migration, 
and proliferation through the MAPK pathway [25,26].
I observed that ln-5 expression is upregulated by PDGF- 
BB and transforming growth factor (TGF-|31) in vitro, 
suggesting that ln-5 may be involved in mediating VSMC 
response to PDGF-receptor induced proliferation in 
pathological states such as restenosis and 
atherosclerosis. My results reveal that stimulation of 
VSMC with PDGF-BB reduced VSMC adhesion to ln-5 and 
increased ERKl/2 activation.
I also found that the inhibition of PDGF-BB-stimulated 
MAPK activation using PD98059, a specific inhibitor of 
MEKl and the MAPK cascade, increased VSMC adhesion to 
ln-5. Therefore I postulated that PDGF-stimulated MAPK 
activation negatively regulates VSMC adhesion to ln-5 
and can be reversed by specific inhibitors to MAPK
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activation as well as by soluble plasma factors that 
inhibit MAPK activation. As ln-5 is involved in the 
enhanced migration of various cell types, the increased 
production of and decreased adhesion to ln-5 may 
provide a mechanism for the design of novel and 
interesting targets in the prevention of pathological 
processes associated with the arterial vasculature, 
such as restenosis following angioplasty.
Materials and Methods
Reagents
Tissues were fixed and permeabilized according to 
protocol as previously described [27]. 
Immunohistochemistry was performed according to 
Molecular Probes Enzyme-Linked Fluorescence (ELF) - 97 
Immunohistochemistry Protocol, MP 06600 iMolecular 
Probes: Eugene, OR). Monoclonal antibodies recognizing 
each of the three subunits of laminin-5 (CM6: a3 
subunit; FM3 : (33 subunit; TRl : y2 subunit) were 
provided by Desmos, Inc. (San Diego, CA) . Polyclonal 
antibodies against rat elastin (pAb 4060-1104) and rat 
collagen 1 (pAb 2150-1908) were obtained from 
Biogenesis (Kingston, NH). Secondary goat anti-mouse 
antibodies (B27 63) were obtained from Molecular Probes 
(Eugene, OR) . Epidermal Growth Factor (EGF) , Platelet-
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Derived Growth Factor-BB and -AB (PDGF-BB, PDGF-AB), 
basic Fibroblast Growth Factor (bFGF), and Transforming 
Growth Factor-pi (TGF-pi) were obtained from Calbiochem 
(La Jolla, CA) . a2—, a3— , a6— , P4—, and pi-integrin
blocking peptide were obtained from Santa Cruz 
Biotechnology, Inc. (Santa Cruz, CA). Antibodies to 
ERK1/ERK2 were also obtained from Santa Cruz 
Biotechnology, Inc. (Santa Cruz, CA).
Cell culture
Rat aortic smooth muscle cells explants were isolated 
and passaged as previously described [28].
Subconfluent cell cultures were then lysed and the ECM 
purified using methods previously described [29].
Photobleaching.
Treatment with filtered sunlight: tissues were 
maintained at 27° C in a tinoxid-filter greenhouse at 
constant oxygen (20%) and carbon dioxide (5%) 
concentrations as previously described [31].
Immunohistochemistry.
Tissues were prepared according to Molecular Probes 
ELF-97 Immunohistochemistry Protocol, MP 06600. All 
reactions were performed in a humidified chamber at 25°
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C. Tissue sections were incubated with blocking buffer 
(30 mM Tris-HCl, 150 mM NaCl, 1.0% bovine serum 
albumin, 0.5% Triton X-100, pH 7.5), followed by- 
incubation with primary antibody (1:500 dilution in 
wash buffer: 30 mM Tris-HCl, 150 mM NaCl, pH 7.5) . 
Subsequent incubations with biotinylated secondary 
antibody (1:1000 dilution in wash buffer), streptavidin 
(1:250 dilution in wash buffer) and ELF-97 Substrate 
Reagent (1:20 dilution with ELF-97 Immunohistochemical 
Reaction Buffer) were performed after serial tissue 
incubations with wash buffer. The reaction was 
arrested using stop buffer (25 mM EDTA, 1.0 mM 
levamisole, 0.05% Triton X-100 in IX PBS, pH 8.0) and 
slides mounted in ELF-97 Immunohistochemical Mounting 
Medium from Molecular Probes.
Microscopy.
Stained tissues were visualized using a Leica DM LB 
immunofluorescence microscope (Leica GmbH: Wetzlar, 
Germany) equipped with 4',6-diamidino-2-phenylindole, 
dihydrochloride (DAPI) long-pass and fluorescein-5- 
isothiocyanate (FITC) filter sets. ELF-substrate 
excitation and emission wavelengths are 360 and 535 +/- 
18 nm, respectively. Images were collected using SPOT 
Diagnostic digital imaging photographic equipment in
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bright and darkfield. ÜV band pass (BP) excitation 
filter 340 - 380 nm and long pass (LP) suppression 
filter (425 nm) , were used for the collection of DAPI 
images; 450 - 490 BP excitation filter and 515 LP 
suppression filter were used for the collection of FITC 
images ; 515 - 560 BP excitation filter and 590 LP 
suppression filter were used for the collection of 
rhodamine images.
In situ hybridization
In situ hybridization was performed as previously 
described using digoxigenin-labeled riboprobes 
synthesized from templates subcloned into pCR-XL-TOPO 
from Invitrogen (Carlsbad,CA ) [32]. Rat a3-specific
probe was synthesized using a 992 bp Hindlll fragment 
spanning nucleotides 3377 - 4369 of the full-length rat 
cDNA; P3—specific probe was synthesized using a 999 bp 
Hindlll fragment spanning nucleotides 2687 - 3687 of 
the full-length rat cDNA; y2-specific probe was 
synthesized using a 1329 bp Hindlll fragment spanning 
nucleotides 1122 - 2451 of the full-length rat cDNA.
RT-PCR
RNA was isolated using Guanidinium Isothiocyanate (GIT) 
and processed as previously described [33]. RT-PCR was
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performed as previously described [34] using 20-24-mer 
rat primers: a3 5': TTGGGCGGAATTCCAATTGC 3': 
GACAACACGGCCATCTGCGACATA; p3 5' : TAGGTGCCCGGAAAGATATATG 
3' : TGGCCTGGATCTCTTTCATC; y2 5' : GTATCGAAGGTTACTGCGGA 
3': TTCTGCTAATCTTGTGGCCT.
Western analysis
Proteins were separated by 7.5% SDS-PAGE and 
transferred to Immobilon-P Transfer Membranes from 
Millipore (Bedford, MA) and processed for 
immunoblotting as previously described [35]. Processed 
membranes incubated with primary antibody were then 
incubated with secondary goat anti-mouse IgG-AP from 
Santa Cruz Biotechnologies (Santa Cruz, CA) and exposed 
to NEN CDP-Star chemiluminescence reagent and developed 
on Kodak X-OMAT LS scientific imaging film.
Adhesion assay
Cell adhesion assays were performed as previously 
described using Costar 96-well Cell Culture Cluster 
plates [36] . Plates were coated with purified matrix 
(collagen, fibronectin, vitronectin, poly-L-lysine, 
laminin-1, or laminin-5) at a concentration of 20 ug/mL 
for 1 hour at room temperature. For affinity-captured 
ln-5 assays, untreated wells were coated with anti-ln-5
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mAb. TRI (20 ug/iriL) in 100 mM carbonate buffer (pH 9.3) 
for one hour at 25° C. Wells were then washed with 
phosphate-buffered saline containing 0.2% Tween-20 
(PBST), blocked with 5% blotto, followed by incubation 
for one hour at 25° C with 804G ce 11-conditioned 
medium. Wells were then washed twice with PBST prior 
to assay. Cells were seeded at a concentration of 1.2 
X 10° in cell culture plates with and without ECM in 
the absence of soluble growth factors (DME only) and 
were allowed to attach for thirty minutes at 37° C.
Where applicable, the medium was supplemented with 
medium containing the indicated concentrations of 
integrin-blocking antibodies or peptides, PDGF-BB, 
PDGF-AB, EGF, bFGF, or TGF-ySl. Adherent cells were 
fixed, stained, and the absorbance at 595 nm read using 
a SPECTRAFlour spectrophotometer.
Results
Immunohistochemistry
In adult rats, ln-5 colocalized with collagen I in 
concentric rings of the tunica media of the aorta and 
was found in the basement membrane of the endothelial 
cell layer proximal to the site of elastin staining in 
the internal elastic lamina and along the elastica 
externa of the aorta (Figure 1).
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In situ hybridization
The a3, P3, and y2 subunits of ln-5 were detected by in 
situ hybridization adjacent to fenestrated collagen 
fibrils in the cellular domains of the tunica media 
(Figure 2A). The expression pattern for all three ln-5 
subunits localized to areas where cells were densely 
packed, consistent with previous reports that laminin 
subunits are a component of the arterial media in situ 
and are synthesized by smooth muscle cells in vitro 
[37] .
Immunecytochemistry
Based on my in vivo observation, I hypothesized that 
rat vascular smooth muscle cells express ln-5. To test 
this hypothesis I examined cultured aortic smooth 
muscle cell explants. Immunofluorescence microscopy 
revealed subcellular deposition of a3, P3, and y2 
subunits within one day in culture (Figure 2B).
Western blot analysis of ECM deposition by cell 
cultures revealed expression of a3, P3, and y2 subunits 
within two days of culture (Figure 3A).
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RT-PCR
To demonstrate the accuracy of my in situ and 
immunohistochemical results, I performed RT-PCR using 
oligonucleotide primers specific for each of the three 
subunits including the y2 subunit, specific to the ln-5 
isoform. y2, a3, and P3 chain-specific primers 
produced distinct bands ranging from 2.9 - 3.2 Kb, 
corresponding to alternative splice variants of each 
ln-5 subunit. The relative abundance of the a3 and p3 
chains appears to be similar in the aortic smooth 
muscle cell RNA sources. The expression of the y2 
subunit, which is restricted to the ln-5 isoform, is 
considerably reduced in comparison. These observations 
provide further support of my initial observations that 
the ln-5 isoform is expressed in vascular smooth muscle 
tissue (Figure 3B).
VSMC adhesion to the ECM
To investigate the regulation of VSMC binding to ECM 
substrata, I used a quantitative adhesion assay to 
determine the amount of adhesion to each matrix 
molecule. I observed collagen, fibronectin and ln-5 
support the static adhesion of VSMC with high affinity 
compared to other ECM substrates such as vitronectin 
and ln-1 in the absence of soluble growth factors
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(Figure 4). VSMCs did not adhere in large numbers to 
the negative controls with affinity (naked plastic or 
blotto) or to the ECM proteins vitronectin and ln-1.
As expected, VSMCs adhesion was increased in the 
positive control (poly-L-lysine) as was adhesion to 
fibronectin and collagen. As predicted, both affinity- 
captured ln-5 and purified ln-5 increased VSMC adhesion 
over negative controls.
Integrin-receptor competition studies 
To determine the binding interactions that regulate 
VSMC integrin-mediated VSMC adhesion to ln-5 I used 
a2—, a3—, a6— , pi—, and P4-integrin subunit blocking 
peptides in competition studies. My results 
demonstrated that the pi-integrin subunit positively 
regulates VSMC adhesion to ln-5 (Figure 5A). Addition 
of pi-integrin subunit blocking peptide (2 ug/mL) 
reduced VSMC adhesion to levels approximating adhesion 
to naked plastic, thus demonstrating that the pi- 
integrin subunit may regulate VSMC adhesion to ln-5.
Addition of the P4-integrin subunit blocking peptide (2 
ug/mL) reduced VSMC adhesion compared with ln-5 
adhesion slightly, indicating that the P4-integrin
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subunit may be involved in the ligation of VSMCs to In- 
5 but that it is not the sole p-integrin subunit 
responsible for this ligation, a result supported by 
our earlier results (Figure 5B).
Interestingly, a6-integrin subunit blocking peptide 
only marginally reduced VSMC adhesion to ln-5. 
Competition studies using a6pi demonstrate that 
adhesion is greatly which seems to suggest that the 
a6pi integrin may be responsible for the initial VSMC 
adhesion to ln-5. a6p4 blocking-peptide combination 
also reduced VSMC adhesion to ln-5 to levels that 
approximate p4-blocking peptide alone, indicating that 
this complex may also mediate the initial binding of 
VSMC to ln-5 (Figure 6A).
a2-integrin subunit blocking peptide, however, did not 
reduce VSMC adhesion to ln-5 and thus appears not to be 
involved in the initial binding of VSMCs to ln-5 (data 
not shown). a3-integrin subunit blocking peptide also 
did not significantly reduce VSMC adhesion to ln-5 even 
in conjunction with p-integrin subunit blocking 
peptides, suggesting it is also not involved in the
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major integrin complexes responsible for the initial 
binding of VSMCs to ln-5 (Figure 6B).
I have determined that ln-5 expression by VSMC is 
upregulated in response to platelet-derived growth 
factor (PDGF-BB) and transforming growth factor (TGF- 
pi), but not by epidermal growth factor (EGF) or basic 
fibroblast growth factor (bFGF) in vitro (Figure 7). 
Additionally, I have determined that PDGF-BB, a potent 
mitogen and chemoattractant for VSMC that is induced 
following arterial injury, significantly reduced VSMC 
adhesion to ln-5 (Figure 8).
Discussion
In this study I have used in situ hybridization and 
enhanced immunohistochemical techniques to define the 
expression pattern of ln-5 subunits in neonatal and 
adult animals. My data using the ELF-system confirmed 
the expression patterns previous reported for ln-5 in 
developing rats using standard immunohistochemical 
labeling techniques (data not shown). A direct 
comparison of conventional indirect immunofluorescence 
using fluorescein-labeled secondary antibody with the 
ELF-method, however, confirms that enzyme amplification 
is necessary for the detection of ln-5 in the tissues
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described in this study. This may explain why ln-5 
expression was not detected in vascular tissues in 
earlier studies of this nature.
Low expression levels suggest ln-5 is not a dominant 
substrate, but likely exerts its effects on adhesion 
and migration in concert with more abundant ECM protein 
such as fibronectin and collagen. Other studies 
present the argument that laminin isoforms are 
necessary for smooth muscle development in other 
tissues. Laminin-1 expression is regulated by the 
epithelial-mesenchyme interaction and is required for 
airway and bronchial smooth muscle development after 
fibronectin levels begin to decrease [38]. This 
provides further support for the explanation that low- 
level Ir-5 expression may later be linked to late-stage 
smooth muscle cell development and possibly arterial 
expansion.
VSMCs are the predominant cell type found in the media 
of elastic and muscular arteries of mammals. In 
adults, VSMC are terminally differentiated and control 
blood flow and contraction in response to various 
chemical and mechanical stimuli. However, during the 
formation of atherosclerotic and restenotic lesions.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
9 8
VSMCs revert to a synthetic phenotype characterized by 
a secretory-, proliferative-, and migratory-active 
state.
Following injury, these VSMC are modified from their 
contractile to a dedifferentiated phenotype, which 
enables the VSMC to secrete various ECM proteins, 
migrate into the intima, and to proliferate [39]. The 
purpose of this study was to analyze the functional 
significance of ln-5 expression in adults, an ECM 
molecule which has now been shown to be expressed by 
VSMC, which is upregulated by TGF-pi and PDGF-BB, two 
growth factors induced following arterial injury which 
may regulate SMC responses such as migration and 
proliferation.
The results of this study provide new information on 
two aspects of VSMC-specific ln-5 expression, (1) the 
adhesion to ln-5 and (2) the integrin-subunit 
specificity of VSMC ln-5-specific adhesion. To address 
the first point I provide evidence that ln-5 supports 
the adhesion of VSMC at levels comparable to that of 
fibronectin and collagen, both components of the tunica 
media that serve to promote the attachment and 
spreading of VSMC in vivo and in vitro.
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Previous studies demonstrate that VSMC attachment to 
collagen is mediated through alpl, o2pi,and a3pl 
integrins, while VSMC adhesion to fibronectin is 
mediated by the aSpi and a3pi integrins, respectively 
[40 - 42]. To address the integrin-subunit specificity 
of VSMC ln-5-specific adhesion, I characterized the 
binding interactions that regulate VSMC integrin- 
mediated VSMC adhesion to ln-5 using a2—, a3—, a6— ,P1— and 
P4-integrin subunit blocking peptides in competition 
studies.
The distribution of pl-integrin subunits has been 
previously studied in VSMC and has been reported to 
modulate VSMC adhesion to collagen type IV and 
fibronectin, but has not been characterized in VSMC 
adhesion to ln-5 specifically. My results indicate the 
involvement of the pi-integrin subunit regulation of 
VSMC adhesion to ln-5.
To elucidate the process of VSMC adhesion to ln-5 using 
the p-integrin complex, I tested the a-subunits of the 
laminin binding integrins a3pi and a6pi, the a3 and a6 
subunits. Although the a3 subunit is involved in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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laminin ligation in various cell types, including 
vascular endothelial cells and VSMC [43], my results 
did not strongly implicate the a3 subunit in the 
initial adhesion of VSMC to ln-5. As expected, the a2- 
subunit, part of the collagen-binding a2pi-integrin 
complex, also did not reduce VSMC adhesion to ln-5.
Of the remaining pi-associated a-integrin subunits that 
recognize laminin isoforms (al and a6) that are 
expressed in VSMC, only a6 has been implicated in ln-5- 
specific adhesion [44]. a6-integrin subunit blocking 
peptide did reduce VSMC adhesion to ln-5, suggesting 
that a6 may be a component of the integrin-binding 
complex involved with VSMC ln-5 mediated adhesion.
This observation is bolstered by previous studies that 
indicate the a6-integrin complex is involved in VSMC 
adhesion to other laminin isoforms such as laminin-1 
[45] .
The a6-integrin forms multiple heterodimers with p- 
integrin subunits, including the a6pl- and a6p4- 
integrin complexes, both previously demonstrated to 
mediate cellular adhesion to ln-5 in various tissues
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[4 6] . The a6p4 blocking-peptides in combination also 
reduced VSMC adhesion to ln-5 to levels that 
approximate P4-blocking peptide alone, providing 
support that that this complex, in addition to a6pi, 
may also mediate the initial binding of VSMC to ln-5.
Turning our attention to the formation of the neointima 
after injury or trauma, such as balloon angioplasty, we 
find that both tissue expression of ECM proteins as 
well as expression of growth factors may be involved 
[47]. Immediately following injury, VSMC lose 
myofilaments and their prominent Golgi complex. These 
changes are followed by a loss in contractility and 
they subsequently become competent to migrate and 
proliferate in response to a large variety of mitogens. 
These mitogens include PDGF-BB, the dominant growth 
factor released during neointimal formation following 
balloon angioplasty [48] .
I have determined that VSMC expression of ln-5 in vitro 
is upregulated in response to PDGF-BB and TGF-pi, but 
not by EGF or bFGF, other major growth factors secreted 
after arterial injury or trauma. Adhesion proteins 
such as fibronectin and laminin play important roles in 
maintaining or altering the phenotypic state of cells
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and exert their effects via integrin receptors that 
converge with growth factor receptor-mediated signals 
in the ERK- (MARK-) pathway [4 9]. Thus, the 
observation that ln-5 expression by VSMC is upregulated 
in response to PDGF becomes significant.
Cell migration is one of the biological functions 
proposed for laminin and is required for physiological 
and pathological migratory processes such as wound 
healing and neointima formation. Thus, the In vitro 
observation that VSMC attachment may be reciprocally 
modulated by both growth factors, such as PDGF-BB, and 
the ECM composition provides the basis for my 
hypothesis that VSMC adhesion to ln-5 is reduced by 
PDGF-BB stimulation, while VSMC migration on ln-5 may 
be enhanced [50].
In conclusion, the present study described the role of 
ln-5 as an adhesion protein for VSMC. Furthermore, my 
data suggest that the (31 - and to a lesser extent the 
(34-, integrin modulates VSMC adhesion to ln-5 using the 
a6(31 and a6(34—integrin complexes, respectively. 
Additionally, I observed that the a3(31- and a2(31- 
integrin complexes may not be involved with the initial 
adhesion of VSMC to ln-5. My results also indicate
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that ln-5 production is enhanced by VSMC in culture 
after exposure to PDGF-BB and that VSMC adhesion is 
decreased by PDGF-BB exposure. As ln-5 is involved in 
the enhanced migration of various cell types, the 
increased production and decreased adhesion of VSMC on 
ln-5 may provide a novel and interesting target in the 
prevention of pathological processes associated with 
the arterial vasculature, such as restenosis following 
angioplasty.
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Figure 1. hnmurohistochemica! localization of In-5 expression in tfie developing 
and adult rat aorta (ascending aorta = aa). Early fetal rats a) 14 days p.c. 
b) 16 days p.c. c) 18 days p.c. and d) adult rats stained for y2 subunit 
expression (exclusive to In-5 isoform) after e] autofluorescence removal by 
f) phofobleaching and tissue treatment, using TRl rrAb. reveal dstinct expression 
patterns in thie ECM domains of thiis tissue.
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Figure 2. In situ hybridization and immunofluorescence 
microscopy.
Figure 2A. Hybridization using digoxigenin-labeled 
anti-sense mRNA probes confirmed the detection of ln-5 
subunit expression in this tissue. a) a3 b) y33 and c) 
y2 subunits of ln-5 were detected adjacent to 
fenestrated collagen fibrils in the cellular domains of 
the tunica media whereas d) anti-sense probles to the 
Drosophila gene: Alcohol dehydrogenase lAdh) and sense 
probes to the e) a3 f) ^3 and g) y2 subunits provided 
negative results similar to that of the h) negative 
control performed under similar conditions without 
mRNA-labeled probe.
Figure 2B. ELF-enhanced immunofluorescence microscopy 
revealed subcellular deposition of a3, y33, and y2 chains 
of ln-5 by rVSMC within one day in culture. A) CM6 
mAb. against a3 b) FM3 mAb. against ^3 c) TRl mAb. 
against y2 and d) P0668 pAb. against ln-5 revealed 
detectable levels of ln-5 subunit expression within one 
day of culture and were distinct from e) nmIgG staining 
of this cell line. f) through j) display the phase 
contrast images of these experiments.
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Figure 3. Western analysis and RT-PCR confirm VSMC 
expression of ln-5. Western blot analysis revealed 
expression of ln-5 subunits from VSMC (3A) . Analysis 
of deposited ECM reveals o3 (lanes 1 and 2) , P3 (lanes 
3 and 4), and y2 (lanes 5 and 6) expression as detected 
by CM6, FM3, and TRl monoclonal antibodies, 
respectively. Negative controls (no primary antibody
- lane 7, no secondary antibody - lane 8) did not 
produce detectable bands. Panel 3B, 0.7% agarose gel 
stained with ETBr reveals RT-PCR products using 
forward and reverse primers specific for each ln-5 
subunit (see Methods) produced bands 2.9 - 3.2 kb (3B
- right lanes) while forward primers only produced no 
bands (3B left lanes).
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Figure 4. VSMC adhesion to the ECM. ECM proteins were 
plated at 20 ji,g/raL for 1 hour at 25° C prior to assay. 
Relative absorbance was measured at 595 nm and the results 
graphed using sample mean and standard error. Graphs 
represent data collected from four independent experiments, 
n=32.
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Figure 5. VSMC adhésion assay using p-integrin receptor 
competitive inhibitors and purified ln-5. p and p/a- 
integrin subunit blocking peptide(s) were added to cell 
suspension media 20 minutes prior to assay. Relative 
absorbance was measured at 595 nm and the results graphed 
using sample mean and standard error. Graphs represent 
four independent experiments, n=32.
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Figure 6. VSMC adhesion assay using oc-integrin receptor 
competitive inhibitors and purified ln-5, a and ot/p- 
integrin subunit blocking peptide(s) were added to cell 
suspension media 20 minutes prior to assay. Relative 
absorbance was measured at 595 nm and the results graphed 
using sample mean and standard error. Graphs represent 
four independent experiments, n=32.
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Figure 7. Western Analysis of cultured VSMC. Western 
analysis of VSMC culture at two days confirmed the 
production of ln-5 in vitro (y2 subunit seen above,), 
with expression of all three ln-5 subunits detectable 
(ct3 and P3 data not shown) . EGF and bFGF also 
inhibited the secretion of extracellular ln-5 compared 
to base-line controls. TGF-pi, PDGF-AB, and PDGF-BB 
increased ln-5 synthesis and deposition more than 
baseline controls. In vitro ECM collection using 
NH4OH, TRl mAb against the y2 chain of ln-5, and 
multimark protein ladder in a 10% separating gel.
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Figure 8. VSMC adhesion in the presence of PDGF-BB. 
PDGF-BB (10 ng/mL) was added to adhesion assay media 
in the presence or absence of pi-integrin subunit 
blocking peptide. Relative absorbance was measured 
at 595 nm and the results graphed using sample mean 
and standard error. Graphs represent data collected 
from four independent experiments, n=32.
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CHAPTER 5
ERKl/2 ACTIVATION IS INVOLVED IN VASCULAR SMOOTH MUSCLE 
CELL PROLIFERATION AND MIGRATION IN RESPONSE TO 
PDGF-BB STIMULATION ON LAMININ-5.
This chapter has been submitted for publication to 
Experimental Cell Research and is presented in the 
style of that journal. The complete citation is:
Kingsley, K. , Huff, J.L., Rust, W.L., Carroll, K. , 
Martinez, A.M., and Plopper, G.E. July 2001. ERKl/2 
activation is involved in vascular smooth muscle cell 
proliferation and migration in response to PDGF-BB 
stimulation on laminin-5. Experimental Cell Research.
Abstract
During restenosis following angioplasty, vascular 
smooth muscle cells (VSMC) change from a 
differentiated, contractile phenotype to a 
dedifferentiated, migratory, and proliferative 
phenotype. Several growth factors, cytokines, and 
extracellular matrix (ECM) components released 
following injury have been implicated in these 
phenotypic changes. In this study I analyzed the 
relationship between the ECM and these growth factors 
with respect to VSMC proliferation and migration in
126
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vitro. I hypothesized that the ECM molecule laminin-5 
(ln-5), recently localized to VSMC, may differentially 
affect the phenotype of VSMC and may serve to mediate 
VSMC responses to growth factors. I found that ln-5 
expression by VSMC is upregulated by growth factors and 
that ln-5 enhanced both the proliferative and migratory 
response of VSMC to platelet-derived growth factor 
(PDGF-BB). I tested the possibility that PDGF- 
stimulated mitogen-activated protein kinase (MAPK) 
activation is responsible for the increased migration 
on ln-5. I found that inhibition of MAPK using 
PD98059, a specific inhibitor of MAPK activation, 
decreased PDGF-stimulated VSMC migration on ln-5.
These results suggest that PDGF-stimulated VSMC 
migration on ln-5 is partially dependent upon MAPK 
activation and that VSMC response to ln-5 may be 
involved in mediating PDGF-stimulâtion in pathological 
states such as restenosis and atherosclerosis.
Introduction
Two major events contribute to the remodeling of the 
arterial vasculature following injury [1]. The first 
event is the migration of VSMC from the arterial wall 
(tunica media) into the vessel lumen, contributing to 
the initial formation of the neointima. The second
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event is the subsequent proliferation of neointimal 
VSMCs, leading to neointimal thickening and further 
vessel occlusion. Both VSMC migration and the 
subsequent proliferation are characteristic, 
pathological VSMC behaviors central to the formation of 
restenosis after injury, produced in response to an 
array of growth factors and ECM proteins secreted 
locally at the sites of vascular remodeling [2].
Several growth factors, cytokines, and ECM proteins 
released following injury have been implicated in these 
phenotypic changes. For example, polypeptide growth 
factors derived from platelets, macrophages, 
endothelial cells, and VSMC themselves are though to be 
partly responsible for these phases of VSMC migration 
and proliferation associated with restenosis [3].
Growth factors demonstrated to be VSMC mitogens in 
vitro and thought to mediate phenotypic changes in vivo 
include basic fibroblast growth factor (bFGF), 
epidermal growth factor (EGF), transforming growth 
factor beta-1 (TGF-pi), and platelet-derived growth 
factor-BB (PDGF-BB) [4-6]. These factors, while not 
usually expressed in the normal artery wall, are 
secreted after injury following angioplasty. These 
cytokines and growth factors regulate VSMC responses
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through ligation and activation of receptor tyrosine 
and serine-threonine kinases.
In addition to the release of soluble growth factors, 
the increased production of ECM proteins can affect 
growth and migration in response to growth factor 
stimulation in a number of different cell types, 
including VSMC [7]. Initially, the migration of VSMC 
requires secretion of proteolytic enzymes to dissolve 
the surrounding ECM, which embeds VSMC of the tunica 
media [8]. This digestion is then followed by the 
secretion of promigratory ECM substrates that support 
transluminal migration in response to the localized 
release of growth factors [9].
A component of the ECM, the laminin isoform, ln-5, is 
composed of three subunits designated a3, P3, and y2. 
Expression of the pS and y2 subunits have only been 
found in ln-5 while the a3 subunit is found in both In- 
6 and ln-7. Ln-5 is expressed in distinct temporal and 
spatial patterns in developing epithelial tissues, 
including VSMC, and influences tissue
compartmentalization and cellular phenotypes from early 
embryonic development onward [10,11].
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The pathogenesis and pathophysiology of restenosis is 
directly influenced by the altered expression and 
topographic redistribution and restructure of ECM 
components, such as collagen, elastin, fibronectin, and 
laminin, through changes in ECM adhesion facilitated by 
integrins as well as in response to locally secreted 
growth factors [12-14]. My results indicate that VSMC 
expression of ln-5 is upregulated in vitro by exposure 
to both PDGF-BB and TGF-pi. Based upon these 
observations I hypothesized that ln-5 expression may 
differentially affect the phenotype of VSMC by 
mediation of VSMC response to these growth factors. To 
test this hypothesis, I analyzed the relationship 
between ln-5 and growth factor-stimulated proliferation 
and migration in vitro.
VSMC migration is dependent not only upon interaction 
with the ECM through integrin receptors, but also 
through growth factor receptor activation. Growth 
factors mediate these synchronized cellular events, at 
least in part, through the mitogen-activated protein 
kinase (MAPK) pathway, a point of convergence between 
integrin receptor-activated pathways and growth factor 
receptor-activated pathways. To further understand the 
mechanisms contributing to VSMC migration into the
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lumen, the first major event in vascular remodeling, I 
examined the effect of the ECM environment on VSMC 
migration using well characterized in vitro transwell 
migration assays.
I found that while collagen IV and fibronectin 
supported increased haptotactic migration of VSMC, ln-5 
only supported marginal VSMC migration. To examine the 
differential effects of the ECM on chemotactic 
stimulation, I exposed VSMC plated on ln-5 to 
chemotactic stimuli and found that bFGF, EGF, and TGF- 
pi did not stimulate VSMC migration on ln-5 whereas 
PDGF-BB-stimulâtion greatly enhanced VSMC migration on 
ln-5.
Furthermore, VSMC stimulation with PDGF-BB increased 
ERK 1/2 activation in vitro, so we tested the 
possibility that PDGF-BB-stimulated MAPK activation is 
responsible for the increased migratory phenotype on 
ln-5. My results revealed the inhibition of MAPK 
activation using PD98059, a specific inhibitor of MEKl 
and the MAPK cascade, decreased VSMC migration on ln-5 
and also increased VSMC adhesion to ln-5.
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These results suggest that PDGF-BB-stimulated VSMC 
migration on ln-5 is partially dependent upon 
intracellular signaling through the MAPK signaling 
cascade. Furthermore, PDGF-stimulated MAPK activation 
negatively regulates VSMC adhesion to ln-5 and can be 
reversed by specific inhibitors to MAPK activation.
Interestingly, ln-5 exhibited an effect as a VSMC 
mitogen, elevating the proliferative response of VSMC 
in the absence of serum compared with control cell 
populations. Additionally, ln-5 significantly altered 
the proliferation of VSMC in response to PDGF-BB, while 
exhibiting little or no effect on the proliferative 
response to bFGF, EGF, or TGF-pi . Based on these 
observations, I suggest that VSMC expression of ln-5 
may be involved in mediating VSMC response to PDGF- 
receptor induced proliferation and migration in 
pathological states such as restenosis and 
atherosclerosis.
Materials and Methods
Reagents
Epidermal Growth Factor (EGF), Platelet-Derived Growth 
Factor-BB and -AB (PDGF-BB, PDGF-AB), basic Fibroblast 
Growth Factor (bFGF), Transforming Growth Factor-pi
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
1 3 3
(TGF-pi), collagen, and fibronectin (FN) were obtained 
from Calbiochem (La Jolla, CA). PD98059 (MEKl
inhibitor) was obtained from New England Biolabs, Inc. 
(Beverly, MA). Anti-erk (p42/p44) rabbit polyclonal 
IgG was obtained from Santa Cruz Biotechnology, Inc. 
(Santa Cruz, CA).
Cell culture
Cells were maintained in 100 mm x 20 mm Corning tissue- 
culture dishes (Plainfield, NJ) at 37° C and 5% CO2 in 
humidified chambers. Rat aortic smooth muscle cells 
explants were isolated and passaged as previously 
described [18]. Cells were maintained in Dulbecco's 
Modified Eagle's Medium High Glucose supplemented with 
10% Fetal Bovine Serum and 1% L-Glutamine (29.2 mg/rtiL) , 
Penicillin G (10,000 units/mL), and Streptomycin 
Sulfate (10,000 mcg/mL) (GPS) from Irvine Scientific 
(Santa Ana, CA).
Western analysis
Subconfluent cell cultures were lysed and the ECM 
purified using methods previously described [19] . 
Proteins from normalized cell populations were 
separated by 7.5% or 10% SDS-PAGE and transferred to 
Immobilon-P Transfer Membranes from Millipore (Bedford,
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MA) and processed for immunoblotting as previously- 
described [20]. Processed membranes incubated with 
primary antibody were then incubated with secondary 
antibodies and exposed to NEN CDP-Star
chemiluminescence reagent and developed on Kodak X-OMAT 
LS scientific imaging film.
Antibodies.
Primary monoclonal antibody (mAb.) to all three 
subunits of ln-5 (CM6: a-3 subunit; FM3 : P-3 subunit;
TRl, y-2 subunit) as well as purified ln-5 matrix were 
generously provided by Desmos, Inc. (San Diego, CA). 
Secondary antibodies were goat anti-mouse IgG-AP from 
Santa Cruz Biotechnologies (Santa Cruz, CA) , donkey 
anti-goat-AP obtained from Research Diagnostics 
(Flanders, NJ), and goat anti-mouse-AP obtained from 
Molecular Probes (Eugene, OR).
Proliferation assay
Tissue culture plates, 100 mm x 20 mm Corning tissue- 
culture dishes (Plainfield, NJ), were either coated 
with purified matrix (collagen, fibronectin, or ln-5) 
at a concentration of 20 ug/mL for 1 hour at room 
temperature. Cells were seeded at a concentration of 
1.2 X 10^ in cell culture plates with and without
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fibronectin, ln-5, collagen, or poly-L-Lysine and were 
allowed to attach overnight. Cells were then starved 
in serum-free DMEM for 4 8 hours to induce quiescence. 
The medium was then replaced with fresh medium 
containing the indicated concentrations of PDGF-BB, 
PDGF-AB, EGF, bFGF, or TGF-pi. Cells were counted at 
one - six day intervals as indicated by removing them 
from the culture wells with trypsin/EDTA, staining them 
with Trypan Blue Stain from Gibco Life Technologies 
(Rockville, MD) and using a VWR Scientific Counting 
Chamber (Plainfield, NJ).
Adhesion assay
Cell adhesion assays were performed as previously 
described using Costar 96-well Cell Culture Cluster 
plates [21]. Tissue culture plates were coated with 
purified matrix (ln-5) at a concentration of 20 ug/mL 
for 1 hour at room temperature. Wells were then washed 
twice with PBST prior to assay. Cells were seeded at a 
concentration of 1.2 x 10® in cell culture plates with 
and without ECM in the absence of soluble growth 
factors (DME only) and were allowed to attach for 
thirty minutes at 37°C. Where applicable cells were 
first incubated for 20 minutes with the indicated 
concentrations of PD98059 in suspension and the
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adhesion media was supplemented with the indicated 
concentrations of PDGF-BB. Cells were counted at the 
end of a thirty minute interval, fixed, stained, and 
the relative absorbance measured using a TECAN 
SPECTRAFlour spectrophotometer at 595 nm.
Migration assay
Cell migration assays were performed as previously 
described in Costar transwell filter plates [22]. 
Filters were either coated with purified matrix 
(collagen, fibronectin, or ln-5) at a concentration of 
20 ug/mL for 1 hour at room temperature. Filters were 
then washed twice with PBST prior to assay. Cells were 
seeded at a concentration of 1.2 x 10® in transwell 
chamber filters with and without ECM in the presence or 
absence of soluble growth factors and were allowed to 
migrate for eighteen hours at 37° C. Where applicable, 
the medium was supplemented with medium containing the 
indicated concentrations of peptides, PDGF-BB, PDGF-AB, 
EGF, bFGF, or TGF-pi. Cells were counted at the end of 
the eighteen hour interval as indicated quantified with 
the following modification. Thirty minutes prior to 
measuring migration, 5 uM calcein AM (Molecular Probes) 
was added to the migration wells. To quantitate 
migration, cells were removed from the top of the
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filter with cotton-tipped applicators and fluorescence 
of the incorporated calcein was measured from the 
bottom of the filter with a fluorescence plate reader 
[23]. Relative fluorescence values for each 
experimental condition are expressed relative to 
control, untreated samples.
Statistics
The differences between untreated and treated cell 
populations v/ere measured using t-distribution. So 
long as the sample size is even moderate (>20) for each 
group, quite severe departures from normality make 
little practical difference in the conclusions reached 
from these analyses [24]. All samples were measured 
using two-tailed t-tests, as departure from normality 
can make more of a difference in a one-tailed than a 
two-tailed t-test.
Results
Western analysis of ln-5 expression 
ECM collected from VSMC cultured from 2 - 6  days 
(representative results at 2 days for the y2 subunit of 
ln-5 are shown) confirmed the production of ln-5 by 
VSMC in vitro (Figure 1). In untreated cells (DME 
control) , expression of all three ln-5 subunits was
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detectable. Exposure of cells to EGF (10 ng/mL) and 
bFGF (10 ng/mL) induced the secretion of extracellular 
ln-5 comparable to baseline controls (DME control). 
TGF-pi (10 ng/mL), PDGF-AB (10 ng/mL), and PDGF-BB (10 
ng/mL) significantly enhanced ln-5 deposition, in sharp 
contrast to the effects of both EGF and bFGF.
Migration assays
The relative stimulatory effects of ECM molecules on 
VSMC migration has not yet been fully determined. 
Therefore, I performed a series of haptotactic 
migration assays to determine the nature of VSMC 
migration on various ECM including ln-5. Because the 
molecular basis for VSMC migration has also not been 
fully elucidated, the roles of chemotactic, soluble 
growth factors present during vascular remodeling 
reported to stimulate VSMC migration are also not fully 
known. Therefore, I performed in vitro migration 
assays to characterize the combinatorial effects of 
growth factor stimulation and ln-5 deposition on VSMC 
migration.
Haptotactic migration
Purified matrix proteins were tested separately for the 
ability to stimulate migration of rat aortic VSMC over
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18 hours through transwell migration filters in the 
absence of soluble growth factors (Figure 2). The 
level of migration in uncoated filters did not vary 
significantly between experiments and was considered 
our negative control. Maximum migration was obtained 
when the cells were exposed to media containing 10% 
fetal calf serum and was referred to as chemotaxis.
To determine if the ECM could elicit migration in the 
absence of soluble growth factors, the basal face of 
transwell filters were coated with indicated 
concentrations of proteins to support the haptotactic 
migration and subsequent adhesion of VSMC (Figure 2).
I observed increased VSMC migration, approximately 55 - 
60% over negative controls with collagen IV-coated 
filters and 40 - 45% with fibronectin-coated filters. 
Ln-5-coated filters stimulated only 10 - 15 % migration 
over negative controls consistently, the lowest 
haptotactic-stimulated migration of any ECM protein 
tested. Results are representative of three 
independent experiments (P < 0.05 untreated plastic:In- 
5, n = 24), (P < 0.05 untreated plastic :FN, n=24), (P < 
0.05 untreated plastic : collagen, n=24).
Chemotactic migration
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To determine if soluble growth factors could elicit 
VSMC migration on ln-5-coated filters, transwell 
chambers were supplemented with 5 - 2 5  ng/ml of bFGF, 
EGF, TGF-pi, and PDGF-BB (Figure 3). The stimulation 
of VSMC with bFGF, EGF, or TGF-pi over the indicated 
concentrations did not significantly affect migration 
of VSMC on ln-5-coated filters (P > 0.1, n = 24). In 
contrast, PDGF-BB-stimulated migration of VSMC on ln-5 
was enhanced from 5 - 2 5  ng/mL in a dose-dependent 
manner, increasing haptotactic ln-5 migration at 5 
ng/mL, further increasing haptotactic ln-5 migration to 
35 - 45% at 10 ng/mL, and saturating with a 50% 
increase over haptotactic ln-5 migration at 25 ng/ml 
PDGF-BB (P < 0.005 ln-5:ln-5 + PDGF-BB 10 ng/ml, n = 
22), (P < 0.005 ln-5:ln-5 + PDGF-BB 25 ng/ml, n = 22). 
The addition of PDGF-BB at doses above 25 ng/ml did not 
further enhance VSMC migration on ln-5 (data not 
shown) .
Western analysis of MAPK levels
Previous studies have shown that PDGF-BB-stimulâtion of 
VSMC is associated with ERK1/ERK2 or MAPK 
phosphorylation, activation, and upregulation. To 
determine levels of MAPK, subconfluent cultures 
consisting of equal numbers of VSMCs were pretreated
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with 10% FCS, PDGF-BB and TGF-pi, then lysed and 
prepared for immunoblotting as previously described 
(Figure 4). My results revealed low levels of p44/p42 
(MAPK) using a rabbit polyclonal IgG in negative 
controls of quiescent VSMC (DME control cells).
Similar low p44/p42 levels were obtained with cells in 
the presence of TGF-pi. As expected, the presence of 
PDGF-BB, as well as 10% FCS, markedly increased 
detectable p44/p42 levels.
MAPK-inhibited migration assay
To determine whether or not the PDGF-BB-stimulated 
increase in VSMC migration on ln-5 is a function of 
MAPK activation, cells were pretreated for 20 minutes 
using PD98059 and the migration media supplemented with 
PD98059, a specific inhibitor of MEKl and the MAPK 
cascade (Figure 5). My results revealed that the 
inhibition of MEKl and MAPK activation using PD98059 
decreased VSMC migration on ln-5 over 18 hours over the 
range of 20 ng/mL - 40 ng/itiL (P < .05, n = 24) .
MAPK-inhibited adhesion assay
To determine whether or not PDGF-BB-stimulated VSMC 
migration correlates with a reduction in VSMC adhesion 
on ln-5 in response to increased MAPK activation and
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increased MAPK levels, cells were pretreated for 20 
minutes using PD98059 (Figure 6). The inhibition of 
MEKl and MAPK activation using PD98059 increased VSMC 
adhesion slightly and abolished the PDGF-BB-stimulated 
reduction in VSMC adhesion to ln-5 (P > 0.4, n= 22).
VSMC proliferative response to ECM
To test the effects of ECM in the absence of exogenous 
growth factors, quiescent VSMC were plated in cell 
culture plates coated with and without blotto, ln-5, 
collagen, poly-L-Lysine, and fibronectin in serum-free 
DMEM for one - four days. I determined discernible 
increases in cellular proliferation over DMEM- 
maintained control cells with each ECM, although the 
amount of cell proliferation varied between the various 
ECM molecules over a period of four days. Results after 
two days clearly demonstrate these effects on cellular 
proliferation (Figure 7). Fibronectin-, ln-5-, and 
collagen-stimulated VSMC grew at least two-fold more 
than DMEM-maintained controls (P < 0.02, n= 24) . 
Representative results of three independent experiments 
are shown.
VSMC proliferative response to growth factors
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To test the effects of growth factor stimulation in the 
presence of exogenous ECM, quiescent VSMC plated on In- 
5 were stimulated with bFGF (10 ng/rtiL) , EGF (10 
ng/mL) , PDGF-BB (10 ng/mL) , and TGF-pl (10 ng/mL) . I 
determined no statistically discernible increase in 
cellular proliferation over DMEM-maintained control 
cells measured after three days in bFGF- and EGF- 
stimulated VSMC plated on ln-5. TGF-pi inhibited 
cellular proliferation over DMEM-maintained control 
cells over three days reducing cell number by almost 
40%, while control cells continued to grow at rates 
consistent with bFGF- and EGF-experimental controls (P 
<0.02, n = 24). Furthermore, I determined that 
initially (day 1) VSMC did not respond to PDGF-BB- 
stimulation. However a marked increase in cell 
proliferation was discernible after two days, 
surpassing controls by more than 40%. This increase in 
cellular proliferation was sustained over time by PDGF- 
stimulation of VSMC, increasing cell number by more 
than 90 % over controls after three days (P < 0.001, n= 
24) .
Discussion
In many models of restenosis, the involvement of VSMC 
can be categorized into three distinct phases of
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cellular response [25]. The initial phase is 
characterized by VSMC proliferation within the tunica 
media, immediately followed by the second phase when 
VSMCs migrate across the intima. Following the 
transluminal migration, VSMCs proliferate further, 
characteristic of the third and final phase of VSMC 
response in the formation of the neointimal layer.
Each phase of cellular response is the cumulative 
reaction of VSMC to a complex network of stimuli that 
include altered ECM deposition and secretion, and the 
localized release of growth factors.
In the present study, I provide evidence that VSMC 
adhesion to ln-5 is significantly reduced in the 
presence of PDGF-BB, a potent stimulator of VSMC 
migration into the intima and of subsequent VSMC 
proliferation, that is released following vascular 
injury. PDGF-BB has been demonstrated to be a VSMC 
mitogen in vitro and is thought to mediate phenotypic 
modulation of VSMC migration and VSMC proliferation in 
vivo through MAPK activation and stimulation [26,27] .
To date, however, little is known about the 
intracellular signaling pathways controlling VSMC 
adhesion and migration in comparison to the broad 
knowledge of signal transduction cascades involved with
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proliferation. These observations regarding VSMC 
phenotype in the presence of PDGF-BB provide the first 
evidence of intracellular signaling involved in VSMC 
behavior on ln-5, a substrate recently localized to the 
tunica media [28] that is upregulated by PDGF-BB 
stimulation of VSMC.
The distinct phenotypes and behaviors associated with 
PDGF-isoform stimulation are the products of 
intracellular signaling pathways that are ultimately 
responsible for the observed physiological effects. 
Previous studies have characterized the PDGF-mediated 
effect on protein kinase C activation, phospholipase C 
activation, phosphatitlyinositol 3-kinase activation, 
increased intracellular calcium, 1,2-diacylglycerol, 
and MAPK phosphorylation [29 - 31]. From these and 
other studies, it has been determined that all three 
isotypes of PDGF (PDGF-AA, PDGF-AB, and PDGF-BB) 
activate MAPK, with PDGF-BB characterized as the most 
potent agonist of MAPK stimulation and transcriptional 
activation. These studies suggest that PDGF-BB 
activates the MAPK pathway by triggering RAS-RAF 
activation, which causes MEKl phosphorylation and 
activation, which then phosphorylates ERKl and ERK2, 
leading to further increases in ERKl/2 levels in VSMC.
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Our data confirmed that the presence of PDGF-BB 
markedly increased measurable p44/p42 levels in VSMC, a 
possible link to the observed reduction of VSMC 
adhesion to ln-5.
No previous investigations have identified whether MAPK 
mediates VSMC adhesion on ln-5. Removal of MAPK 
activation and stimulation through the use of PD98059, 
a specific inhibitor of MEKl and the MAPK signaling 
cascade, lowered overall MAPK levels while 
simultaneously increasing VSMC adhesion to ln-5 in the 
presence of PDGF-BB. Based on these observations, I 
suggest that PDGF-BB-stimulated MAPK activation 
negatively regulates VSMC adhesion to ln-5.
Additionally, I hypothesized that ln-5 may also serve 
to differentially affect the migration of VSMC in 
response to growth factors, such as PDGF-BB. I found 
that while collagen IV and fibronectin support 
significant levels of VSMC haptotactic migration (>
40%), ln-5 does not. When growth factors were used to 
assay VSMC chemotaxis on ln-5, these studies revealed 
that EGF, bFGF, and TGF-pi did not stimulate 
chemotactic VSMC migration on ln-5, whereas PDGF-BB
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stimulation greatly enhanced VSMC migration on ln-5 (> 
50%) compared to controls.
As PDGF-BB-stimulâtion produced measurable increases in 
VSMC p44/p42 levels, I hypothesized that the 
upregulation of MAPK activation by PDGF-BB stimulation 
may be responsible not only for the reduced adhesion of 
VSMC to ln-5, but also that PDGF-BB-stimulated 
increases in VSMC migration on ln-5 are at least 
partially dependent upon intracellular signaling 
through the MAPK signaling cascade. The inhibition of 
MAPK activation through the use of PD98059 
significantly reduced In-5-mediated VSMC migration in 
the presence of PDGF-BB, suggesting that PDGF-BB- 
stimulated VSMC migration on ln-5 may be dependent upon 
intracellular signaling through MAPK. Furthermore, 
PDGF-stimulated MAPK activation negatively regulates 
VSMC adhesion to ln-5 and can be reversed by specific 
inhibitors to MAPK activation.
In this study I have also shown that culturing VSMC on 
exogenous ECM can have distinct effect on cell 
proliferation. Cells cultured on ln-5, as well as 
collagen and fibronectin, proliferate more rapidly than 
control cells. In addition, I have determined that
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although EGF and bFGF can only marginally affect cell 
proliferation on ln-5, the effects of TGF-(31 and PDGF- 
BB produce drastic changes in VSMC phenotype. TGF-pi 
strongly inhibited the proliferation of VSMC even in 
combination with exogenous ECM stimulation of VSMC.
In sharp contrast to TGF-pi, the effects of PDGF-BB 
positively alter cell proliferation on ln-5. Although 
VSMC controls can be stimulated to increase 
proliferation solely with the addition of PDGF-BB to 
the culture media, the presence of ln-5 significantly 
increased the effect of PDGF-BB-stimulâtion of VSMC.
The levels of cell proliferation were greater than 
either results obtained with the growth factor alone or 
ECM in isolation (data not shown).
The upregulation of ECM secretion in the sites of 
injury and the release of PDGF and other growth factors 
imply that complex synergistic interactions exist that 
may drive the pathological phenotype of VSMC following 
vascular injury. That VSMC proliferation is enhanced 
by exogenous ln-5 exposure and PDGF stimulation is 
consistent with current models linking ECM proteins 
such as FN and ln-1 to the proliferative phenotype of
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VSMC in pathological states such as atherosclerosis and 
restenosis.
Thus, the relationship in VSMC proliferation and 
migration on ln-5 in the presence of growth factors 
such as PDGF-BB in vitro suggests that ln-5 may be 
involved in mediating VSMC response to PDGF-receptor 
induced proliferation and migration in pathological 
states such as restenosis and atherosclerosis.
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Figure 2. Haptotactic migration of VSMC. Purified matrix 
proteins (20 /ig/mL) were tested separately for the ability 
to stimulate migration of VSMC over 18 hours through 
transwell migration filters in the absence of soluble 
growth factors. Emission and excitation wavelengths were 
4 85 and 530, respectively. The results were graphed using 
sample mean and standard error.
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Figure 3. Chemotactic migration of VSMC. Soluble 
growth factors were tested for the ability to stimulate 
migration of VSMC on ln-5 (20 p.g/mL) over 18 hours 
through transwell migration filters in the presence of 
EGF-, bFGF-,PDGF-BB,and TGF-^l-stimulation at the indicated 
concentrations.
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Figure 4. VSMC iysate after 30 
minute chemokine exposure. SDS- 
PAGE and western blot anti-ERKl/2 
(p42/p44) using polyclonal rabbit 
IgG revealed differing VSMC response 
in levels of ERKl/2 production upon 
stimulation with growth factors.
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Figure 5. MAPK-inhibited migration of VSMC. PD98 05 9 at the 
indicated concentrations was added to cell migration media 
containing PDGF-BB (25 ng/mL) 20 minutes prior to 18 hour 
transwell migration assays.
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Figure 6. MAPK-inhibition adhesion assay. The adhesion of 
VSMC in the presence of PD98059 at the indicated 
concentrations was measured for the effect on PDGF-BB 
stimulation at 25 ng/mL. Absorbance was read at 595 nm and 
the results graphed using sample mean and standard error.
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Figure 7. VSMC proliferative response to the ECM after 
two days of growth. Quiescent VSMC were plated in cell 
culture plates coated with and without blotto, ln-5, 
collagen, poly-L-Lysine, and fibronectin (20 /tg/mL) 
in serum-free DMEM.
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tested for the ability to stimulate VSMC proliferation over 
a period of three days.
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CHAPTER 6
GENERAL DISCUSSION
Summary and. Conclusions
In this study, I sought to determine temporal and 
spatial patterns of ln-5 expression in non-epithelial 
tissues. Using an enzyme-linked immunofluorescence 
amplification system and a newly developed 
photobleaching treatment, I observed ln-5 expression 
in previously undocumented sites including the aorta, 
pulmonary arteries, bone, and cartilage. In this 
study I demonstrated the spatial and temporal 
regulation of ln-5 isoform expression in the 
developing tissues of the rib and examined the 
expression of ln-5 during embryonic vasculogenesis as 
well as in the adult animal.
Based on my in vivo observations, I hypothesized that 
rat vascular smooth muscle cells in the arterial 
vasculature express ln-5 and in the remainder of this
166
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study, I attempted to analyze the functional 
significance of ln-5 expression.
As the initial phase of VSMC in response to injury or 
trauma is characterized by VSMC proliferation within 
the tunica media, I analyzed the relationship in VSMC 
proliferation between ln-5 and growth factors that have 
been demonstrated to be VSMC mitogens in vitro and are 
thought to mediate phenotypic modulation of migration 
and proliferation in vivo. My results demonstrate that 
ln-5 significantly altered the proliferation of VSMC in 
response to PDGF-BB, a potent mitogen and 
chemoattractant for VSMC. Interestingly, ln-5 
expression is also upregulated by PDGF-BB and TGF-pi, 
suggesting that ln-5 may be involved in mediating VSMC 
response to PDGF-receptor induced proliferation in 
pathological states such as restenosis and 
atherosclerosis.
My studies also demonstrated that ln-5 is able to 
support cell proliferation in the absence of PDGF- 
stimulation, however the combination of ln-5 
upregulation in the sites of injury and the release of 
PDGF and other growth factors indicate that more 
complex synergistic interactions exist that may drive
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
1 6 8
the pathological phenotype of VSMC following vascular 
injury.
Based on these observations I sought to determine the 
binding interactions that regulate VSMC ligation to In- 
5, specifically determining the receptors responsible 
for integrin-mediated VSMC adhesion to ln-5. My results 
indicated that the a6pi— and a6p4- integrin complex may 
be responsible, at least in part, for the initial VSMC 
adhesion to ln-5.
I also observed that while other ECM molecules such as 
collagen IV, laminin-1, fibronectin, and vitronectin 
support haptotactic migration of VSMC, ln-5 does not.
I found that EGF, bFGF, and TGF-pi, polypeptide growth 
factors also release after injury, do not stimulate 
chemotactic VSMC migration on ln-5, whereas PDGF-BB 
stimulation greatly enhanced VSMC migration on ln-5.
I hypothesized that ln-5 may differentially affect the 
migration of VSMC and may also serve to mediate the 
migratory response of VSMC to growth factors such as 
PDGF-BB.
I postulated that PDGF-BB-stimulated MAPK activation is 
responsible for the increased migratory phenotype of
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VSMC on ln-5. The results revealed that stimulation of 
VSMC with PDGF-BB reduced VSMC adhesion to ln-5 and 
concomitantly increased VSMC migration on ln-5 while 
stimulating ERKl/2 activation. The inhibition of PDGF- 
BB-stimulated MAPK activation using PD98059, a specific 
inhibitor of MEKl and the MAPK cascade, decreased VSMC 
migration on ln-5 while increasing VSMC adhesion to In- 
5.
These results suggest that PDGF-BB-stimulated VSMC 
migration on ln-5 is at least partially dependent upon 
intracellular signaling through the MAPK signaling 
cascade and more specifically through ERK1/ERK2 
activation. Furthermore, PDGF-stimulated MAPK 
activation negatively regulates VSMC adhesion to ln-5 
and can be reversed by specific inhibitors to MAPK 
activation as well as by soluble plasma factors that 
reduce MAPK activation.
Previous studies have demonstrated that growth factor- 
directed VSMC migration is dependent upon both 
interaction with the ECM through integrin receptors and 
on growth factor receptor activation. I determined 
that the a6pi, and the a6p4 integrin complex may be 
responsible for the initial VSMC adhesion to ln-5.
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In addition, I determined that ln-5 affected the 
migration of VSMC and may serve to mediate the 
migratory response of VSMC to growth factors such as 
PDGF-BB specifically through ERK1/ERK2 activation. 
Furthermore, PDGF-stimulated MAPK activation negatively 
regulates VSMC adhesion to ln-5 and can be reversed by 
specific inhibitors to MAPK activation as well as by 
soluble plasma factors that reduce MAPK activation.
As ln-5 is involved in the enhanced migration of 
various cell types, the increased production and 
decreased adhesion of VSMC on ln-5 may provide a 
mechanism for the design of novel and interesting 
targets in the prevention of pathological processes 
associated with the arterial vasculature, such as 
restenosis following angioplasty. The use of anti­
oligonucleotide therapy and other site-specific 
negative regulators of ln-5 expression may provide 
additional methods to be used in the prevention of 
pathological processes associated with the arterial 
vasculature, such as restenosis.
Recommendations
Atherosclerosis is one of the leading causes of death 
in the United States. Intervention treatments such as
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
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balloon angioplasty have remained effective treatments 
for severe arterial stenosis [1,2]. These therapies 
are limited by the development of intimai hyperplasia 
(restenosis) in the area of the treated lesion in up to 
50% of these procedures [3]. Due to the tremendous 
number of patients affected by atherosclerosis and 
restenosis following angioplasty, the development of 
therapies to prevent and decrease restenosis has become 
a medical imperative.
Over the past three decades, a number of approaches 
have been tested to try to decrease the rate of 
restenosis. These treatments fall into four major 
categories; (1) implantation of coronary stents during 
angioplasty procedures, (2) post-operative infusion of 
antibodies against specific integrin receptors involved 
in VSMC migration, (3) oral administration of growth- 
factor antagonists following angioplasty, (4) and 
localized gene therapy delivered locally during the 
angioplasty procedure.
Although coronary stents, oral medications, and anti- 
integrin antibody infusions have demonstrated the 
ability to reduce angiographic restenosis rates 
significantly, a great need still existed for improved
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therapies that further decrease or eliminate the 
formation of restenotic lesions following angioplasty 
[4,5]. Several characteristics of gene therapy have 
made localized administration an extremely promising 
and attractive method for the prevention and treatment 
of coronary restenosis.
For instance, gene therapy is capable of delivering the 
therapeutic agent specifically to the location of the 
clinical manifestation, the site of injury in the 
arterial wall [6] . Secondly, gene therapy may 
precipitate fewer non-site specific side effects 
associated with either post-operative infusion of 
antibodies against specific integrin receptors or with 
the oral administration of growth-factor antagonists 
following balloon angioplasty [7].
Many gene therapies have been focused on the inhibition 
of VSMC proliferation as cellular proliferation of VSMC 
has long been held to be one of the primary 
pathological processes in the development of 
restenosis. Many traditional therapies and treatments 
including oral medications and the more recently 
experimental gene transfer mechanisms were designed to 
inhibit specific cell cycle regulators such as cyclin-
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dependent kinases, transcription factors, and 
transcription initiation factors such as the 
retinoblastoma protein, Rb [8 - 10]. The rationale for 
the use of these targets has been to block events that 
are directly linked to cellular proliferation, such as 
progression through the cell cycle.
These therapies have been met with limited success due 
to several key elements that must be considered en 
masse. First, these therapies have tended to focus on 
the principle that VSMC proliferation is the key 
mechanism involved in the formation of restenotic 
lesions. We know understand that two major events 
rather than just one contribute to the remodeling of 
the arterial vasculature following injury. The first 
event is the migration of proliferating VSMC from the 
media into the vessel lumen, contributing to the 
initial formation of the neointima. The second event 
is the subsequent proliferation of neointimal VSMCs, 
which leads to neointimal thickening and further 
occlusion. Thus, therapies that focus exclusively on 
the arrest of the cell cycle may prove toxic to 
adjacent cells or tissues, weaken the arterial wall, or 
even disrupt normal arterial healing necessary 
following angioplasty [11].
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An emerging group of gene therapies focus not on the 
arrest of progression through the cell cycle, but 
rather upon the prevention of VSMC migration into the 
intima. Several targets have been proposed that may 
limit the migration of VSMC, including growth-factor 
activated intracellular signaling pathways, 
cytoskeletal reorganization components, upregulated 
matrix metalloproteases, and various families of 
upregulated ECM molecules [12, 13].
These therapies offer many potential approaches to the 
inhibition of initial VSMC cell migration, one of the 
first events involved in the formation of the 
neointima. PDGF functions primarily as a chemotactic 
agent but also a potent mitogen for VSMC. The 
inhibition of specific, PDGF-stimulated intracellular 
signaling pathways may eventually prove to be effective 
targets for gene therapy aimed at limiting VSMC 
migration and subsequent VSMC proliferation in the 
neointima. In fact, the administration of antisense 
PDGF-p receptor oligonucleotide has already been 
demonstrated to act as an antagonist to injured rat 
arteries and has demonstrated the ability to
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
1 7 5
significantly reduce hyperplasia and neointimal 
formation following angioplasty [14]-
Thus, by targeting different aspects of the vascular 
injury response, the overall prevention and treatment 
of hyperplasia and restenosis can be improved 
dramatically. My studies suggest the involvement of 
ln-5-mediated migration, adhesion, and proliferation in 
the VSMC response to arterial injury and thus suggest 
that ln-5 can be considered a candidate in the paradigm 
for localized gene therapy during angioplasty. I now 
consider possible methods for the design and 
implementation of anti-ln-5 therapies against 
restenosis.
To design an effective treatment using ln-5 as a 
target, three major factors must be considered. The 
first of the factors is the selection of the most 
appropriate target combined with the most efficient 
method of altering or inhibiting the target to yield 
the best results for patient outcome. The second 
factor is the selection of the most appropriate vector 
to deliver the therapy to the localized site of injury, 
in this case the wall of the artery undergoing 
angioplasty. The final factor is the mechanical
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delivery system for the transferal of the vector to the 
site of injury.
Potential gene targets
Many targets have the potential to alter some of the 
many physiological processes involved in arterial 
remodeling. These targets include, but are not limited 
to mRNA encoding cell-surface integrin receptors 
specific for ln-5 involved in the phenotypic 
transformation of VSMC, or alternatively may include 
mRNA encoding the polypeptide subunits of ln-5 involved 
in these VSMC phenotypic changes. The selection of 
initial targets should logically be given to mRNA 
targets that encode for products that are secreted by 
cells, so that the likely effects of transfer would 
effectively be amplified by a paracrine mechanism.
Based on these considerations mRNA encoding the 
subunits of ln-5 would seem likely candidates as their 
expression is limited to the synthetic, premigratory, 
proliferative phenotype exhibited following injury and 
would not otherwise negatively affect the normal 
function of VSMC or other cells involved in normal 
arterial wall function or the normal wound healing 
response.
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Ln-5 is a heterotrimeric protein, comprised of three 
separate polypeptide units encoded by distinct genes 
(Figure 1). The a3 chain in humans is encoded by the 
LAMAS gene (5433 bp) located at 18qll.2, which is 
responsible for producing splice variants of 150 and 
165 kDa [15]. The a3 chain is not specific to ln-5, 
shares high homology to other a-subunits, and is 
shared among other laminin isoforms, specifically as 
part of the ln-6 (a3piyl ) and ln-7 (o3p2yl) 
heterotrimers. These features make the a3 mRNA a less 
attractive target due to the lack of specificity to In- 
5 and the strong possible overlap between the a3 chain 
and other laminin a-subunits.
The y2 chain of ln-5 is encoded by LAMC2 (517 5 bp), 
which is located lq25-31 and is responsible for the 
production of the 100-, 105-, 125-, and 140-kDa splice
variants [16]. The y2 mRNA is homologous to the 
laminin p-chains but differs from the P2- and p3-chains 
in that it had no domain VI and domains V, IV, and III 
were truncated. The y2 chain is not a component of 
other laminin isoforms and thus initially presents 
itself as a strong candidate for our therapeutic
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target, although the shared homology between p- and y- 
subunits may negatively impact the specificity of our 
targeted therapy.
The p3 chain of ln-5 is encoded by LAMBS (3616 bp), 
which is located at lq32, is responsible for the 
production of the 125- and 140-kDa polypeptide splice 
variants [17]. The laminin P3 chain gene, like the Gr­
and y-gene counterparts, shares high homology to the 
human genes encoding the homologous laminin pi and P2 
chains, LAMBl and LAMB2 respectively. The LAMBl,
LAMB2, and LAMBS also share high levels of homology to 
the genes encoding the y-subunits, however, several 
differences exist. y-subunits exhibit truncation of 
domains V, IV, and III found among the P-subunits. 
Furthermore the y-subunits lack domain VI found among 
the p-subunits, easily making these domains of the P3 
chain the most specific targets among the three ln-5 
subunits (Figure 2).
Thus, having selected the p3-subunit of ln-5 to be the 
most appropriate target I now focus on describing the 
most efficient method of altering or inhibiting this 
target to yield the best results for patient outcome.
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Two basic methods have been employed using gene therapy 
in the treatment of restenosis, (1) the introduction of 
therapeutic gene cassettes into vascular tissues to 
alter gene products, thereby inhibiting some portion of 
the cascade that leads to restenosis or (2) by 
introducing oligonucleotide fragments of coding or 
regulatory genetic material into vascular tissues [18]. 
These fragments function by altering endogenous gene 
expression through competitive inhibition rather than 
by introducing entire exogenous genes, and thus do not 
constitute actual gene transfer but are considered to 
be a form of manipulative gene therapy.
A variety of gene transfer systems have been attempted 
such as plasmid-based gene transfer, retroviral gene 
transfer, and adenoviral gene transfer [19, 20]. These 
methods of gene transfer are relatively inefficient, 
typically transducing between 0.1% and 10% of vascular 
target cell populations. This inefficiency is a by­
product of the large requisite size of the gene 
transfer product and the comparatively low vector 
concentrations achievable using current methods.
One method used to overcome these difficulties is the 
use of oligonucleotide fragments of coding or
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regulatory genetic material into vascular tissues, as 
previously mentioned. These fragments function through 
competitive inhibition by hybridizing with mRNA 
transcripts or genomic transcription initiation sites, 
thereby altering endogenous gene.
The use of antisense oligonucleotides (ASO) has proven 
successful in the acute blockage of cellular 
proliferation. ASO hybridization with mRNA for c-myc, 
has been demonstrated to reduce hyperplasia by as much 
as 65% [21]. These results demonstrated that nonviral 
methods of gene therapy can be more efficient, site- 
specific, and safe.
Thus, of the three major factors we must consider, I 
have selected the pS-subunit of ln-5 to be the most 
appropriate target selection, and that the use of 
antisense oligonucleotides for the VI, V, IV, and III 
domains of the P3-subunit may be the most efficient 
method of altering or inhibiting transcriptional 
activation or translation efficiency. The final factor 
to consider is the mechanical delivery system for the 
transfer of these ASO to the site of injury.
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Mechanical delivery
To deliver ASO at the site of injury two basic 
mechanisms have been utilized, endovascular delivery 
and perivascular delivery [22]. Endovascular delivery 
mechanisms generally employ porous balloon catheters to 
infuse ASO or plasmid suspensions from the arterial 
lumen into the vessel wall. Endovascular delivery 
typically has lower efficiencies in vivo due to the 
kinetics of vector-cell attachment, which is 
significantly slower than the rate of release necessary 
for the limited length of the angioplasty procedure.
Perivascular delivery, in contrast, appears to enhance 
transduction and uptake efficiency, which may be a 
consequence of the restrictions created by the ECM and 
other connective tissue barriers within the layers of 
the artery [23]. Thus, the delivery of antisense 
oligonucleotides for the VI, V, IV, and III domains of 
the pS-subunit or other therapeutic agents may be 
enhanced by perivascular delivery or direct injection 
into the adventitia or tunica media directly at the 
sites of vascular injury (Figure 4).
In summary, I have identified ln-5 expression in the 
arterial vasculature and found that ln-5 stimulates
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proliferation of VSMC, synergistically with mitogenic 
growth factors such as PDGF-BB. Furthermore, I found 
that PDGF-BB stimulated VSMC migration on ln-5, at 
least partially through intracellular activation of the 
MAPK signaling cascade and that this migration can be 
reversed by specific inhibitors to MAPK activation as 
well as by soluble plasma factors that reduce MAPK 
activation.
This constitutes the initial design of a novel 
treatment for restenosis using ln-5 as a target. 
Specifically, the use of antisense oligonucleotides for
the VI, V, IV, and III domains of the p3-subunit 
delivered by perivascular or direct injection into the 
adventitia or tunica media directly at the sites of 
vascular injury may well constitute an additional tool 
and therapeutic treatment option for the reduction of 
restenosis following angioplasty.
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(National Center for Biotechnology 
Information : www. ncbi . nlm. nih. gov)
T.AMA3
Figure 1. LAMA3, LAMB3, and LAMC2 are human genes 
that code mRNA for the ot3, (33 and y2 subunits of 
laminin-5, respectively.
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241 cgagtagaga atgtggcttc atcctccggc cccatgcgct ggtggcagtc ccagaatgat
301 gtqaaccctg tctctctgca qctqqacctg qacaqqaqat tccaqcttca aqaaqtcatq
361 atggagttcc aqqqqcccat qcctqccqqc atgctgattg agcgctcctc aqacttcggt
421 aagacctqgc qaqtqtacca gtacctqqct qccqactqca cctccacctt ccctcqqqtc
481 cqccaqqqtc qqcctcaqaq ctqqcaqqat qttcqgtqcc aqtccctqcc tcaqaqqcct
541 aatqcacqcc taaatqqggq qaaqqtccaa cttaacctta tqqatttaqt qtctqqqatt
601 ccaqcaactc aaaqtcaaaa aattcaaqaq qtqgqgqaga tcacaaactt qaqaqtcaat
661 ttcaccaqgc tqqcccctgt qccccaaaqq qqctaccacc ctcccagcqc ctactatqct
721 qtqtcccaqc tccqtctqca qqqqaqctqc ttctqtcacq qccatqctqa tcqctqcqca
781 cccaaqcctq qqqcctctgc agqcccctcc accqctgtgc aqqtccacqa tqtctgtqtc
841 tqccaqcaca acactqccqq cccaaattqt qaqcqctqtq cacccttcta caacaaccqq
901 ccctqqaqac cqqcqqaqqq ccaqqacqcc catqaatqcc aaaqqtgcqa ctqcaatgqq
961 cactcaqaqa catqtcactt tqaccccqct qtqtttqccq ccaqccaqqq qqcatatqqa
1021 ggtgtgtgtg acaattqccq qqaccacacc qaaqqcaaqa actqtqaqcq qtqtcaqctq
1081 cactatttcc qqaaccqqcg cccqqqaqct tccattcagq aqacctqcat ctcctqcgaq
1141 tqtqatccgq atqqqqcaqt gccaqgqqct ccctqtqacc caqtqaccqq qcagtgtgtg
1201 tqcaaqqaqc atqtqcaqqq aqaqcqctqt qacctatqca agccgggctt cactqqactc
1261 acctacqcca acccgcagqq ctqccaccqc tgtqactqca acatcctqqq qtcccqqaqg
1321 qacatqccgt qtqacqaqqa gagtgggcgc tqcctttqtc tqcccaacqt qqtqqqtccc
1381 aaatqtgacc aqtqtqctcc ctaccactqq aaqctqgcca qtqqccaqqq ctqtqaaccq
1441 tqtqcctqcq acccqcacaa ctccctcaqc ccacaqtqca accaqttcac aqqqcaqtqc
1501 ccctqtcqqq aaqqctttqq tqqcctqatg tqcaqcqctq caqccatccq ccagtqtcca
1561 qaccqqacct atqqaqacqt qqccacaqqa tgccgaqcct qtqactqtqa tttccqqqqa
1621 acaqaqqqcc cqqqctqcqa caaqqcatca qqccqctqcc tctqccqccc tqqcttgacc
1681 qqqccccqct qtqaccaqtq ccaqcqaqqc tactqtaatc qctacccqqt qtqcgtqqcc
1741 tqccaccctt qcttccagac ctatqatqcg qacctccqqq aqcaqqccct qcqctttggt
1801 aqactccqca atqccaccqc caqcctqtqg tcaqqqcctq qqctqgaqqa ccqtqqcctq
1861 qcctcccqga tcctagatqc aaaqaqtaag attgagcaga tccqaqcaqt tctcaqcagc
1921 cccqcagtca caqaqcagqa qqtqqctcag qtqqccaqtq ccatcctctc cctcaqqcqa
1981 actctccagq qcctqcagct qqatctqccc ctqqaggaqq aqacqttqtc ccttccqaga
2041 gacctqgaga qtcttqacaq aaqcttcaat qqtctcctta ctatqtatca qaqqaaqaqq
2101 qaqcaqtttq aaaaaataag caqtqctqat ccttcaqqaq ccttccggat gctgagcaca
2161 gcctacgagc agtcagccca ggctgctcag caggtctccg acagctcgcg ccttttggac
Figure 3. Target sequences for antisense oligomer 
therapy derived from the laminin-5 (33-subunit; exons 
3 - 14, encompassing domains VI, V, IV, and III, 
encoded by the mRNA nucleotides + 298 through +
2137.
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Panel A Panel B
Panel C
Figure 4. Perivascular injection of materials into 
the adventitia or tunica media of arteries. Panels 
A and B demonstrate the design of the perivascular 
injection needle. Panel C demonstrates the site- 
specific localization of the controlled drug 
administration. (Courtesy of www.medscape.com)
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